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ABSTRACT 
Endogenous and exogenous molecular dynamic changes in tissue model systems often 
provide essential information to improve our understanding of these systems. For instance, the 
endogenous changes within tumor tissues induced by interactions between tumor and stroma are 
not only indications of tumor initiation and progression for disease diagnosis and prevention 
purposes, but also an important piece of information for studying the underlying disease 
mechanisms. Similarly, studies of dynamics of exogenous molecules in biological systems, such 
as transdermal diffusion and mass transport across blood vessels, provide both theoretical and 
practical benefits. In order to study these dynamic changes, development of reasonable tissue 
models, clear characterization and understanding of these models and implementation of new 
technologies and methodologies are needed.  
Here, we propose to establish both 3-D in vitro tissue models and animal tissue models 
using the emerging FT-IR imaging technology combined with conventional biological and 
histological tools. These models are then examined for their chemical and biochemical stability, 
and used to monitor tumor-associated changes in stroma and cellular responses and 
transformations upon the stimulation from growth factors and mechanical stress in cellular 
microenvironment. Finally, these issue models are applied to development of new quantitative 
method to study the dynamic diffusion of exogenous molecules in skin and artery tissues using 
FT-IR imaging.  
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CHAPTER 1 
INTRODUCTION 
1.1 Motivation 
Changes in tissue model systems can come from both endogenous and exogenous sources. 
Studies of the molecular dynamics of these changes often provide essential information to 
improve our understanding of these systems. For instance, interactions between tumor and 
normal cells can induce endogenous changes in tissues that are indicative of tumor initiation and 
progression for disease diagnosis and prevention purposes. These changes are also an important 
piece of information for studying the underlying disease mechanisms. Similarly, studies of 
spatiotemporal dynamics of exogenous molecules in biological systems, such as transdermal 
diffusion and mass transport across blood vessels, provide both theoretical and practical benefits.  
Many tissue models have been used as human substitutes in biomedical studies. These 
models can roughly be grouped into two categories, in vitro tissue culture models and animal 
models. In contrast to 2-D cell culture, which is in fact the most widely used in vitro model, 3-D 
tissue culture has recently been increasingly regarded as a more realistic model of the natural 
tissues.1,2,3 While shown to be markedly different compared to 2-D culture and with much more 
controllable features, how precisely current 3-D culture models mimic the anatomical and 
biological environment of human tissues is often unclear. Similarly, animal models are thought 
to be close representations of their human counterparts. Yet a complete histological and chemical 
assessment of the similarity in the context of a specific application is often largely lacking. 
Here, we propose to develop different tissue models that mimic both human tissue 
structure and function, to utilize these models in characterization of molecular changes in tumor 
models and to develop quantitative analytical methods for molecular dynamic applications like 
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drug diffusion (Figure 1.1).  The primary tool we use is FT-IR imaging. This emerging imaging 
technology provides the spatial specificity of optical microscopy with the molecular selectivity 
of vibrational spectroscopy, therefore is a powerful tool in tracking molecular dynamic changes 
in tissue model systems.   
The first main goal of this project is to establish in vitro model systems for our studies. 
The engineered tissue models based on 3-D culture techniques will be used here for fundamental 
studies in cancer biology and for better design of diagnostic imaging techniques. In particular, 
we seek to examine cell-microenvironment interactions, such as epithelial-stromal interactions, a 
key event during tumor progression.4,5 3-D culture can provide a controlled microenvironment 
for studying these interactions. 6 , 7  Structural and chemical changes resulted from these 
interactions need to be observed and quantified for a complete understanding of tumor 
progression.  
The second goal of this project is to characterize animal models with reference to human 
tissues and their applications in studying molecular dynamics of endogenous and exogenous 
compounds, such as drug diffusion. Porcine tissue, especially skin, is regarded as histologically 
close to human tissue.8,9,10 A complete chemical and histological characterization of the porcine 
tissue as a model is needed to demonstrate the applicability of porcine model in human studies. 
FT-IR imaging is used to identify the changes of these exogenous compound and endogenous 
tissue components. Therefore, a combination of animal tissue models and chemical imaging 
technology will likely improve our understanding in molecular dynamic processes like drug 
diffusion.  
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The project will lead directly to tissue model systems for use by researchers in cancer 
biology, imaging and drug development. For example, the knowledge gained will directly 
influence our understanding of the spatial and chemical extent and temporal evolution of 
epithelial-stromal interactions. At the same time these models are critically needed to validate the 
performance of new technology. As part of the project, hence, we will particularly try to 
establish FT-IR spectroscopic imaging for drug diffusion studies. The translation of chemical 
imaging to clinical pathology and pharmaceutical development can be greatly accelerated by 
using these model systems. 
 
1.2 Significance 
1.2.1 FT-IR Imaging is An Emerging New Technique for Many Applications 
Fourier transform infrared spectroscopy (FT-IR) has been widely used for chemical 
characterization in the past few decades.  Its applications are usually on the level of classes of 
molecules, such as carbohydrate abundance, protein secondary structures, or nucleic acid 
expression. In the past two decades it has been rapidly evolved from a traditional one-spectrum-
at-a-time technology into a powerful imaging technology. New large array detectors and 
different data collecting techniques have now turned the measurement results into a data cube 
(Figure 1.2).  XY information can now be collected, which gives the spatial information in a 
sample, but a spectrum is also generated at every pixel.  For every image, there are often 
thousands of associated images, which generate datasets of over tens and hundreds of gigabytes. 
The progress in this field is so rapid that we can now image one centimeter by one centimeter 
area in about three or four seconds, which would take about seven years just twenty years ago. 
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Because FT-IR imaging can provide spatial and chemical information simultaneously, it has 
great potential in many applications. For instance, it has been used to develop new automated 
histopathology tools to improve tumor diagnosis in prostate, breast, colon and other organs. 
11,12,13
 FT-IR imaging is especially useful in studying molecular dynamics of materials, such as 
drug diffusion, as we will demonstrate in this dissertation. 
1.2.2 Development of Melanoma and Prostate Tumor Models Are Beneficial to Public Health 
Skin cancer and prostate cancer are among the most common cancers in the US. A 
majority of human cancers arise within the skin. Though melanoma comprises less than 4% of 
diagnosed skin cancers, it causes over 75% of skin cancer-related deaths and its incidence is 
rapidly increasing.14 Despite decades of scientific research, the sole effective cure is surgical 
excision of the primary tumor15 when the lesions are smaller than 1 mm.16 Hence, early detection 
is critical in melanoma treatment, and the evolution of the tumor and its penetration into the 
dermis are key factors to be studied in understanding the disease.17 Similarly, prostate cancer is 
the most common type of cancer in men in the United States, and the second leading cause of 
male death.18 Much effort has been made to study the prostatic epithelial-stromal interactions, 
which are considered to be one of the most important links driving the “vicious cycle”, a widely-
accepted model describing the tumor developing process.19 Both soluble factors, such as growth 
factors, and insoluble factors, such as solid ECM, are believed to be responsible for the 
communications.20,21,22 The ability to detect these cancers at early stages and to understand the 
fundamental mechanism of these diseases will be needed. Development of in vitro melanoma 
and prostate tissue models can no doubt provide new tools for cancer research and facilitate our 
understanding of these diseases. 
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1.2.3 3-D in vitro Tissue Models are Needed for Cancer Research and Imaging Studies  
A major obstacle in effective cancer research is that it relies heavily on 2-D cell cultures, 
which are not necessarily faithful representations of human tissues. Numerous studies have 
shown that results from 2-D cultures often cannot be reproduced in human studies.23,24 For 
example, the location of tumor and its interactions with multiple cells25,26 make cellular behavior 
in traditional 2-D cell culture less realistic. 3-D tissue culture is generally regarded as more 
realistic representation of the natural tissues, especially because it provides the 3-D environment 
for epithelial-stromal interactions, which are a critical step leading to the tumors. Compared with 
animal models, 3-D culture is often much easier to handle and less time-consuming. It does not 
have the ethical concerns either, which often complicate human and animal studies. 3-D culture 
based engineered tissues are emerging as a powerful tool in many other fields. For example, 
engineered tissue models represent a convenient path to providing models for imaging studies. 
The adoption of engineered tissues for experimental studies in the imaging field holds promise as 
an alternative to the classic phantoms used for decades. However, the lack of widespread use of 
engineered tissues in imaging studies is partly due to the absence of realistic model systems and 
partly due to a lack of easy methods to characterize and compare engineered tissues with human 
tissues. A combination of biochemical and structural knowledge is often helpful and is enabled 
by the emerging fields of chemical imaging27, such as FT-IR imaging.  
1.2.4 Animal Tissue Models Need Further Assessment as Good Models for Human Studies 
Many animal models have been widely used in human disease studies. For example, 
based on morphological and functional data, domestic pig skin seems to be the closest to human 
skin, and is often used as a substitute in various human skin studies. Hence, the similarity of 
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porcine tissues in mimicking human tissues largely depends on the structural and chemical 
similarity to some extent. Both these properties and their evolution over the time should be 
examined as accurate histological reproduction and minimal chemical degradation are critical 
aspects of many tissue models. Finally, tissues are often structurally heterogeneous.28 Hence, 
variations among different samples and of the same histological entities within a sample must be 
accounted to either understand or address reproducibility issues in using these tissue model 
systems. Emerging chemical imaging techniques can potentially aid in this task of 
simultaneously examining chemistry and structure in a dynamic and facile manner. FT-IR 
imaging holistically measures chemical species in the sample and its use in tissues has been 
reported in various biomedical applications.29,30,31,32,33,34,35,36,37,38 
 
1.3 Innovation 
There are several innovations in this project that stem from the development of new 3-D 
engineered tissue models, the characterization of tissue models using a combination of histology 
and FT-IR imaging, and the quantitative analyses of molecular dynamic changes, including 
tumor transformation and drug diffusion using these tissue models. 
1.3.1 Analytical Tools Combining Biological and Chemical Imaging  
While structural characterization of tissue is routinely accomplished by structural 
imaging, a biochemical characterization typically requires destruction of the structure, thereby 
losing spatially specific information. While molecular imaging is dye- or probe-based, chemical 
imaging holistically measures chemical species in the sample using spectroscopy. The desired 
information is then extracted using computational methods. Among the prominent approaches 
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are vibrational spectroscopy, including both Raman and infrared imaging.39 FT-IR spectroscopic 
imaging is useful for the analysis of tissue biopsies and has a well-developed instrumentation and 
data analysis knowledge base. 40,41 Recent compilations42 describe biomedical applications, in 
general, and several reports specifically describe IR spectroscopic studies on human tissue 
samples. However, there are no prior reports, to our knowledge, on analyzing engineered tissue 
models with IR spectroscopic imaging. And while animal tissues are often considered to be close 
representatives of human tissues, a complete characterization of these tissues as model systems 
for human studies is still missing. Therefore, we propose to apply FT-IR imaging in combination 
with conventional histology to study engineered and animal tissues.  
1.3.2 Tumor Associated Transformation Studies in Engineered Tissues 
We systematically examine spectral and spatial properties of engineered tissue models 
with reference to measurements of human tissues, the spectral recognition of tumor and the 
changes in each cell type as a function of tumor progression. In particular, we examine the 
question of stromal involvement in tumor progression. Though the concept was proposed almost 
120 years ago,43 facile methods to measure such a transformation are lacking. While structure 
changes in stroma regions during tumor progression are apparent using histological tools, the 
detection of these changes are often too late for early diagnosis and prevention of tumors. 
Chemical imaging might be able to solve this problem, because chemical changes are likely to 
occur prior to any visible structure changes. Engineered tissues provide a reliable 
microenvironment for tumor and the interactions between epithelial and stromal cells can be 
readily studied in a defined environment. While tumor grades have been related to spectral 
signatures in the prostate for example, 44  specific examination of tumor progression in a 
controlled environment using FT-IR imaging is a novel method in studying cancer biology. By 
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examining the changes introduced by epithelial-stromal interactions in engineered tissues, we 
will shed new light on understanding the fundamental mechanism driving the tumor development.  
1.3.3 Quantitative Analysis of Drug Diffusion Using FT-IR Imaging 
Drug diffusion is an important process. Transdermal drug delivery, for instance, is 
extensively studied, partly because of its significance in pharmaceutical and cosmetic industries. 
Skin is a dynamic, living tissue, and the process by which a drug is transported across the skin, 
especially the stratum corneum (SC) barrier, is a complex process. The exact knowledge of the 
local distribution of a drug topically applied to the skin are important to understand and optimize 
drug delivery efficiency. 45 , 46 , 47  It is reasonable to assume that most necessary information 
relating to permeability can be deduced from the concentration profile of a drug across skin, 
particularly in the SC layer. However, conventional methods are either only suitable to obtain the 
permeated amount of drugs passing through the skin (Franz cell),48,49 or not able to provide 
consistent and accurate quantification with good spatial resolution (tape stripping).50,51 FT-IR 
imaging combined with Attenuated Total Reflectance (ATR) technology has been used to study 
transdermal penetration. However, in many of those studies the experimental setup is similar to a 
Franz diffusion cell, where FT-IR imaging is used to monitor the drug compound permeating 
through the SC layer, instead of the concentration profile of the drug across the skin. We propose 
to use a different experimental design with fresh sample preparations and apply high spatial 
resolution FT-IR imaging to track the drug concentration profiles across the skin in a more 
sensitive and quantitative way. This will likely help improve our understanding of transdermal 
drug diffusion.  
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Apparently, this same methodology can be applied to diffusion in other tissues. For 
instance, diffusion is an essential part of molecular exchange across blood vessels. Similarly, the 
distribution of drugs in tissues released from drug-eluting stents is important information towards 
the optimization of the efficacy of stents. Hence, our new method of using FT-IR imaging to 
study molecular dynamics will like provide a powerful tool for many applications in different 
fields. 
 
1.4 Summary 
In summary, we propose here to establish engineered and animal tissue models, and use a 
combination of biological and chemical imaging techniques to study the molecular dynamic 
changes, including tissue stability, tumor-associated changes in stroma and molecular diffusion 
in tissue models. This work will provide the cancer research community with a new analytical 
method to characterize the extent of tumor influence, give the tissue engineering community a 
powerful tool in measuring holistic chemical changes during the development and maturation of 
samples, present the spectroscopy community access to model systems for studying cancer 
progression, and finally provide the cosmetic and pharmaceutical industries a platform for drug 
test and delivery studies.  
This dissertation is organized into seven chapters. The current chapter intends to give a 
brief introduction of background and the motivations. More details about each aspect of this 
thesis work will be discussed in the other six chapters, which are organized as following: 
Chapter 2 describes development and preliminary characterization of 3-D cell culture and 
co-culture tissue models. In this chapter, two 3-D cell culture models, skin and prostate, will be 
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presented.  Cell culture in a microfabricated bioreactor will be also briefly introduced. This 
forms the foundation of our research in molecular dynamic changes in tissue model systems. 
Chapter 3 intends to use the engineered skin as an example of our studies of endogenous 
changes in tissue models. FT-IR imaging will be used to demonstrate its capabilities in structural 
and chemical characterizations of tissue models. In particular, tumor-associated changes in 
stroma will be investigated using FT-IR imaging, showing the important epithelial-stromal 
interactions. 
Chapter 4 is dedicated to study interactions between cells and their microenvironment. 
TGF-β1 and mechanical signals will be shown as examples of soluble and insoluble factors in 
cellular microenvironment, respectively. They will be used to induce molecular changes in 2-D 
and 3-D cultures systems, which can be monitored and quantified using various imaging tools. 
Chapter 5 is focused on animal tissue models, in particular, the porcine skin tissue model. 
The chemical properties, including its stability, of porcine skin will be examined and compared 
to human skin, to pave the way of using porcine skin as a human substitute in chemically-related 
processes, such as molecular diffusion studies. 
Chapter 6 shows our novel approach in transdermal drug diffusion studies. This is a 
perfect example of how FT-IR imaging, combined with tissue models, can facilitate our 
understanding of otherwise complicated molecular dynamics processes.  
Chapter 7 is another application of our novel quantitative imaging method in diffusion 
studies in blood vessels. In addition, the tissue chemistry and histology will be examined using 
high resolution infrared imaging, the most recent development of the IR imaging technology. 
11 
 
1.5 Figures 
 
Figure 1.1 The concept of the thesis work. (A) In vitro skin and prostate tissue models 
and animal models are developed and evaluated using 3-D tissue culture and various 
imaging tools. (B) Chemical characterization of tissue models including their 
chemical stability using FT-IR imaging technique. (C) Tissue models are used for 
cancer studies to understand specific changes in time and space during tumor 
initialization and progression. (D) Quantitative methods for studying diffusion 
dynamics in tissue models. 
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Figure 1.2 FT-IR spectroscopic imaging. New array detectors can now turn the FT-IR 
measurements into a data cube, where the spatial information (XY) can be obtained at 
the same time spectra (Z) are generated at every pixel. The technology development 
in the past two decades has dramatically reduced the data collection time, making 
imaging of large area possible. 
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CHAPTER 2 
DEVELOPMENT OF 3-D CELL CULTURE  
AND CO-CULTURE TISSUE MODELS 
2.1 Introduction 
Before we can study the molecular changes in biological tissue models, these models 
need to be developed and evaluated. We will focus on the development of 3-D cell culture and 
co-culture models in this chapter. 
2.1.1 2-D and 3-D Cell Culture 
One of the major obstacles for cancer studies is that they are still heavily relying on 2-D 
cell culture. 2-D cell culture is one of the most commonly used methods in cancer research. 
However, recent evidence indicated that many results from 2-D cell lines grown on 2-D plastic 
surfaces cannot be validated in clinical studies.1,2,3,4 It’s not surprising given that cancer cells are 
very variable and their behaviors are easily regulated by extracellular microenvironment and 
culture conditions. Therefore, animal models often have to be used in many cases as an 
alternative. However, animal models also have their inherent limitations, such as their labor-
intensive nature and high cost, and their lack of direct translation to human cancer studies.3,5 
The introduction of in vitro 3-D tissue models has improved the capacity of these studies. 
In contrast to the traditional 2-D cell culture, 3-D tissue culture is generally regarded as more 
realistic representation of natural tissues, especially because it provides the microenvironment 
for the epiethelial-stormal interactions, which is a critical step leading to tumors.6,7 What’s more 
important is that in vitro 3-D culture provides easy control of this cellular microenvironment that 
often has direct impact on components of tumor progression pathways. For instance, soluble 
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factors can be added or extracted to influence tumor development in 3-D culture. Compared with 
animal models, 3-D culture is easy to handle and both time and cost effective. 
2.1.2 3-D Engineered Tissue Models 
Current 3-D in vitro tissue models often employ the methodology from emerging tissue 
engineering area, such as culturing cells in 3-D extracellular matrix (ECM), either natural 
polymers like matrigel and collagen, or synthetic polymers like poly-lactic-co-glycolic acid 
(PLGA).8 ,9  These models are becoming more and more popular due to their advantages of 
availability, controllability and time/cost-saving potentials. However, it is still a challenge to 
develop tissue structures that represent natural tissues, which raises the question of how reliable 
current models are in term of their suitability as the substitutions of natural tissues in cancer 
studies. Therefore, a tissue model that has the precise control of its structures that mimic the 
natural tissues will be highly appreciated. 
2.1.3 Skin Tissue 3-D Culture 
Skin cancer is among the most common in the US. A majority of human cancers arise 
within the skin. Though melanoma comprises less than 4% of diagnosed skin cancers, it causes 
over 75% of skin cancer-related deaths and its incidence is rapidly increasing.10 Despite decades 
of scientific research, the sole effective cure is surgical excision of the primary tumor when the 
lesions are smaller than 1 mm.11,12 Hence, early detection is critical in melanoma treatment, and 
the evolution of the tumor and its penetration into the dermis are key factors to be studied in 
understanding the disease.13 
Skin has relatively simple laminar epidermis and dermis layers with additional accessory 
structures. Skin is still largely functional without these accessory structures.33 Therefore, it is 
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relatively less complicated to engineer the skin model with structure of epidermis and dermis 
layers. The engineering process mostly involves 3-D layered cell culture, which has been 
regularly used in our lab.14,15 
2.1.4 Prostate Tissue 3-D Culture 
Prostate cancer is the most common type of cancer in men in the United States, and the 
second leading cause of male death. 16  Prostate cancer cells reside in a three-dimensional 
microenviroment. A “seed and soil” relationship was initially proposed by Paget more than 100 
years ago to describe how cancer cells and their host interact, where the host (soil) is a silent 
bystander that only influences the dissemination of tumor (seed) in patients.17 However, it is now 
well accepted that the interaction is actually reciprocal and far more dynamic than the seed and 
soil model. In normal prostate tissues prostate epithelial cells interact with their adjacent stroma 
through various soluble and insoluble factors and keep the tissue homeostasis, while in prostate 
tumors epithelial cells have undergone genetic changes and therefore provoke a chain reaction of 
changes in their surrounding stroma, which in turn modulate cancer epithelial cells and promote 
their stroma independence and eventually tumor metastasis. This is the so-called “vicious cycle” 
model.18 This reciprocal interaction essentially drives the most of tumor development process, 
and the stroma activation is one of the most important links during the cycle.  
3-D culture has been used to study prostate tumor progression and metastasis.19 These 
tissue models typically involve either cell culture in ECMs to form aggregate spheroids in 
various conditions. However, a defined structure that mimics natural prostate tissue is still 
largely lacking. 
2.1.5 Cell Culture in Microfabricated Bioreactors  
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One of the major obstacles in the tissue engineering field, especially for researchers 
working towards building large 3-D tissues, is the lack of microcirculatory system for tissue 
culture.20 In natural tissues most of cells stay within a distance of about 100 µm from nearby 
capillaries.21 However, in many 3-D cell culture systems, the nutrition source is often much 
farther away, and embedded cells often suffer from the lack of nourishment. It has been reported 
that cells in a tissue are poorly cultured when they are further than 400 µm away from external 
nutrient sources.22,23 Therefore, capillary perfusion is essential in supplying nutrient and oxygen 
for cell growth. Microfabrication technologies have been used by many research groups to 
develop methods to enhance the mass transport in tissues. For instance, straight artificial blood 
vessels were inserted into the tissues, 24  but this method is unlikely to work in complex 
interconnecting tissues like prostate. 3-D printing technology is also a popular choice, but it 
doesn’t have a resolution that is close to capillary dimension.25  Other attempts include silicon 
microfabrication of micro channels for enhanced mass transport26 and co-culture of various cell 
lines to induce endothelial vessel networks.27 However, the mass transport in thick tissue culture 
still remains a problem in tissue engineering. Professor Nicholas Fang’s group has developed an 
innovative 3-D microfabrication technology, called projection micro-stereolithography, for the 
design and the fabrication of vascularized microbioreactors.28,29 This technology has been shown 
to dramatically enhance the nutrition and growth of cultured cells through capillary networks,30,31 
and will be used in our studies here. 
2.1.6 In vitro Tissue Models for Imaging Studies 
Engineered tissues are emerging as a powerful tool in many other fields. For example, 
engineered tissue models represent a convenient path to providing models for imaging studies. 
The adoption of in vitro tissue models for experimental studies in the imaging field holds 
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promise as an alternative to the classic phantoms used for decades. However, the lack of 
widespread use of engineered tissues in imaging studies is still relatively rare. More realistic 
model systems will certainly help increase their popularity. At the same time, new methods to 
characterize and compare engineered tissues with human tissues are also necessary. As an 
example, a combination of biochemical and structural knowledge is enabled by the emerging 
fields of chemical imaging32, which will be discussed throughout of this dissertation. 
 
2.2 Materials and Experiments 
2.2.1 Monolayer 2-D Cell Culture  
Fibroblast cell line MRC-5 (ATCC, Rockville, MD) was cultured in 75 cm2 tissue culture 
flasks with Minimum Essential Medium Eagle (MEME) supplemented with 10% fetal bovine 
serum (FBS) and 1% pen/strep (complete medium) at 37°C with 5% CO2. The cells were 
harvested from monolayer culture with 0.25% trypsin/1mM EDTA. Trypsin was neutralized with 
10% FBS MEME. The cells with the 4-15th passage were used. Prostate epithelial cell line 
LNCap (ATCC, Rockville, MD) was cultured in RPMI-1640 medium using similar procedure.  
2.2.2 3-D Cell Culture  
3-D collagen matrices were prepared from collagen I (8.69 mg/ml, BD Biosciences, high 
concentration, rat tail). Collagen solution was diluted and neutralized with complete medium and 
1N sodium hydroxide to 2.0 mg/ml to make the collagen gels without cells. Cells were added to 
the collagen solution to make the collagen gels with cells. To make the layer structure of 
collagen gels, aliquots of collagen or cell/collagen mixtures were placed in the wells of Corning 
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48-well culture plates. Polymerization of collagen matrices was completed in 30 min at 37°C. 
More layers were added with the same procedure if necessary. Complete medium was applied to 
the top of gels after polymerization. 
2.2.3 Immunocytochemical Staining 
Immunocytochemical staining (ICC) was performed on cells grown in 35 mm glass 
bottom dishes with 10 ng/ml TGF-β1 stimulation for 3 days. Culture medium was subsequently 
removed and the cell monolayer was 3× washed with ice-cold TBS; the cells were fixed with 4% 
paraformaldehyde at room temperature (RT) for 15 min; 3×5 min/each washed with TBS at RT; 
permeabilized with 0.1% TX-100 in TBS for 15 min, at RT; rinsed thoroughly with TBS, 3×5 
min/each. Following fixation, the cells were incubated with 1% BSA for 20 min, at RT; then 
washed 3× TBS, 5 min/each, at RT. Subsequently, the cells were incubated with primary 
monoclonal α-SMA antibody (1:100, 10 µg/ml) in TBS (1% BSA) at RT for 1 hr, followed by 
3× TBS wash, 5 min/each, at RT. Cells were then incubated in secondary antibody conjugated 
with HRP (Dako kit), at RT for 1 hr, followed by 3× TBS wash, 5 min/each, at RT. DAB 
substrate (20 µl in 1ml buffer, Dako kit) was used to develop the color for 5~10 min. The 
samples were sealed with mounting medium and taken for imaging. 
2.2.4 Immunofluorescence Staining 
In 2-D culture, cells were washed with ice-cold TBS and fixed with 4% 
paraformaldehyde at RT for 15 min, followed by 3× 5min/each wash with TBS at RT. Cells were 
permeabilized with 0.1% TX-100 in TBS for 15 min, and rinsed thoroughly with TBS, followed 
by 3× wash in TBS 5min/each. Cells were then incubated with 1% BSA for 20 min, followed by 
3× wash in TBS 5 min/each. Cells were then incubated in primary monoclonal α-SMA antibody 
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(1:100, 10 µg/ml) in TBS (1% BSA) at RT for 1 hr, followed by 3× wash in TBS, 5min/each. 
Cells were then incubated in secondary antibody conjugated with fluorescence dye (1:200) in 
TBS (1% BSA), at RT for 1 hr, followed by 3× TBS wash, 5 min/each. Samples were mounted 
with anti-photobleaching reagent, sealed with glass coverslips and then taken for imaging.  
3-D collagen gels were fixed with 4% paraformaldehyde at 4°C overnight before the 
layers of each gel were separated. 0.15 M glycine in PBS was added to the gels for 10 min to 
quench the paraformaldehyde. Gels were then washed and permeabilized in 0.02% TX-100 in 
PBS for 15 min followed by 5% non-fat milk blocking for 2 hr. Gels were then incubated with 
primary monoclonal α-SMA antibody (1:100 in 1%BSA/PBS/T) overnight at 4°C and secondary 
antibody (1:200 in 1%BSA/PBS/T) at RT for 2 hr. Cell nuclei were stained with TO-PRO 3 
(1:1000 in PBS) for 20 min before gels were mounted between two glass coverslips with anti-
photobleaching reagent. 
2.2.5 Confocal Microscopy Imaging 
All gels were examined with a Leica SP2 laser scanning confocal microscope (Leica, 
Heidelberg, Germany) with Hg lamp and helium/neon laser. 488 nm excitation wavelength was 
used for FITC and 633 nm excitation wavelength was used for TO-PRO 3. For each gel, a series 
of images were captured along z-coordinate (the depth of gel) in the same lateral area and the 
imaging step size is 3-5 µm.  
2.2.6 SDS–PAGE and Western Blotting 
2-D cultured cells were washed with ice-cold PBS and lysed under addition of 1% TX-
100, 50 mMTris-HCl (pH 8.0), 150 mMNaCl, and 1:1000 diluted protease inhibitor cocktail 
(Sigma-Aldrich). Cell lysates were incubated on ice for 10 min and then centrifuged at 13,000 
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rpm for 10 min at 4°C. The supernatant was collected. The total protein concentration was 
quantified via the BCA protein assay reagent kit (Sigma-Aldrich), adjusted by adding 
appropriate amounts of lysis buffer, subsequently mixed with 2× loading buffer (Bio-Rad 
Laboratories), and stored at 4°C. Proteins were separated by SDS-PAGE Ready Gels (10% Tris-
HCl, Bio-Rad Laboratories) with glycine-Tris running buffer in a Bio-Rad’s PowerPac™ HC 
electrophoresis system at 100V for 60 min. A routine blotting technique was used to transfer 
protein to the membrane (Bio-Rad Ready Gel Blotting Sandwiches). Membranes were blocked 
with 5% fat free milk in Tris-buffered saline with Tween 20 (50 mMTris–HCl, 150 mMNaCl, 
0.1% Tween 20, pH 7.4). Proteins were detected by incubating the membranes with primary 
monoclonal α-SMA antibody (1:1000, 1 µg/ml) for 1 hr at RT. After subsequent washing, 
horseradish peroxidase (HRP)-conjugated secondary anti-mouse (1:5000; Sigma-Aldrich) was 
applied for 1 hr at RT. Peroxidase activity was recorded on a Fluorchem 8900 imager using the 
supersignal west picochemiluminescent substrate (Pierce). β-actin was used as a protein control. 
2.2.7 Cell Live/dead Assay or Viability Assay 
The LIVE/DEAD® Viability/Cytotoxicity assay kit (Invitrogen) was used to monitor cell 
viability of the cell culture. It is a two-color fluorescence staining system. The calcein AM is 
cleaved by intracellular esterase of live cells and shows green fluoresecence, while ethidium 
homodimer (EthD-1) can enter broken cell membrane of dead cells and stain the nuclei in red 
fluorescence. After harvesting cells, 2 µM calcein AM and 4 µM EthD-1 was added to the 
surface of cell culture dishes or cover slips. Incubations should be performed in a covered dish 
for 30–45 mins at room temperature to prevent contamination or drying of the samples. 
Fluorescence of cells were then viewed under the Zeiss Axiovert 200M fluorescence microscope 
(Zeiss). 
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2.2.8 Hematoxyline and Eosin Staining 
Tissues placed on slides were de-paraffinized using Xylene and were subsequently 
rehydrated using solutions of 100%, 95%, 70% Ethanol and deionized water. Slides were then 
stained with Hematoxylin for 5 mins and Eosin for 30 sec with subsequent dehydration in a 
series of gradient Ethanol and Xylene. Images of stained tissues were acquired using a 
VistaVision inverted microscope (VWR ). 
2.2.9 Projection Micro-Stereolithography 
The process was developed at Professor Nicholas Fang’s group. It started from 
generating 3D structure in Computer Aid Design (CAD) software. Then the structure was sliced 
into a sequence of bitmap images, each of which represents a thin layer of the 3-D structure. The 
thickness of each layer varies from 2 to 30 micro meters. In each fabrication cycle, one image 
was displayed on the dynamic mask and the modulated light pattern was then delivered by the 
light engine composed of beam splitter and 45o mirror to the reduction lens. The reduced image 
was focused on the photo curable liquid surface. The whole layer was polymerized 
simultaneously. After one layer was solidified, the polymerized part was immersed deep into the 
liquid surface to allow a new thin liquid layer atop. A new fabrication cycle started again. By 
repeating the cycles, a 3-D microstructure was formed from the stack of layers.  
2.2.10 Bioreactor Cell Culture  
Both MRC-5 fibroblasts and LNCap epithelial cells were cultured in flasks/dishes using 
regular monolayer cell culture protocols until they reached 60~80% confluency. Bioreactors 
were transferred from soaking medium to a new Petri dish and the medium inside the bioreactor 
was removed using sterile Kimwipe paper. MRC-5 cell
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medium mixed with pre-chilled matrigel before they were transferred to the inner chamber of the 
bioreactor. The bioreactor was kept in the 37oC incubator for 5 mins for matrigel to solidify. The 
bioreactor was carefully flipped and LNCap cells resuspended in medium was seeded to the 
other side of the bioreactor. The bioreactor was transferred to the dish and covered with medium, 
and kept in the incubator for 30 mins. Additional 3 ml medium was supplied to submerge the 
bioreactor.  Culture medium was then renewed every 2 days. 
 
2.3 Results 
2.3.1 In Vitro Skin Tissue Models 
Skin has a relatively simple laminar structure consisting of epidermis and dermis layers 
with various accessory structures (Figure 2.1A). Although accessory structures often play 
important roles in skin functionalities, lack of them does not change the essential function of the 
skin.33 In other word, skin is still largely functional without these accessory structures in most of 
applications. To engineer skin tissue constructs, a “layered deposit” approach is used to make 
epidermis layer on top of a dermis layer. This approach is essentially 3-D co-culture of epithelia 
cells and fibroblasts in extracellular matrix. The 3-D skin model is engineered and cultured in 
vitro (Figure 2.1B, C). It consists of 8-10 layers of normal human epidermal keratinocytes grown 
on a 1 mm think layer of normal human dermal fibroblasts seeded in collagen gel, which is in 
turn supported by an inert polymer insert with 0.4 µm pore size (Figure 2.2).  
It has been well documented that epidermis cultured in air-media interface shows a 
morphology closely mimicking natural skin epidermis structure.34,35 ,36 ,37 ,38  In particular, the 
stratum corneum layer, the barrier and one of the most important structures in many dermatology 
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studies, has been reported to be developed if the engineered skin is cultured this way. Therefore, 
engineered skin was cultured at the air-media interface and gradually developed into full-
thickness skin structure (Figure 2.3A), which consists of a dermis layer and a fully developed 
epidermis layer, including the stratum coneum substructure (Figure 2.3B). This is important for 
many applications, especially those depending on the barrier function of the stratum corneum. 
Full-thickness engineered skin has been used in many applications, including irritation 
testing. 39 , 40 , 41  It provides an alternative to human subjects in skin testing and has been 
increasingly used in in pharmaceutical and cosmetics industries. Our development of these skin 
models is an important step towards our goal of a holistic characterization of molecular changes 
in tissue model systems. 
To use the in vitro skin tissue model to study the tumor-associated changes, we need to 
modify the full-thickness model into a tumor model. Hence, malignant melanocytes were 
included to build a skin melanoma model. A malignant melanocyte cell line, A375, was mixed 
with and incorporated into the epidermal layer during cell seeding.  Melanoma models were 
cultured for a total time period of 20 days, and were removed and processed using common 
formalin fixation and paraffin embedding histological approaches every other day. We observed 
that tumors were limited to small cell clusters at the beginning of the experiment, but grow larger 
and deeper into the tissue over the time, which can be observed by H&E staining (Figure 2.3C, 
D). This resembles melanoma progression that occurs in natural human skin tissues. However, 
future structural and chemical examination is needed to evaluate how realistic this melanoma 
model is compared with natural human skin. This will be discussed in later chapters. 
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In summary, we have successfully established an in vitro engineered skin tissue model 
and further developed it into a melanoma tumor model. These models have essential skin 
structures, including the important stratum corneum layer. Future applications using these 
models will be discussed later. 
2.3.2 Prostate 
Prostate is a tissue with interconnecting glandular structure (Figure 2.4A), which is more 
complicated than skin. To simplify the problem of engineering this very complex tissue, we 
started with a single unit, a 3-D lumen structure, which can be considered as the building block 
for the entire prostate tissue. This simplification is justified in that our long term goal for this 
model is to study cell-cell interactions in microenvironment. This aspect of functionality is still 
well preserved in our simplified model.  
With the knowledge and experience from engineered skin model, we engineered a simple 
structure to represent a prostate lumen using a syringe and needle system (Figure 2.4B). This 
system is chosen because: 1. it is a simple design for the experiment; 2. the wide range of needle 
sizes can give us flexibility of the size of the lumens; 3. it maintains the sterilized conditions for 
cell culture.  
This simplified prostate tissue model was built in two steps. First, 3-D collagen gel was 
prepared and fibroblast cells were seeded. This is to mimic the stroma region of prostate tissue, 
which is primarily composed of fibroblasts and collagen matrix. A prostate epithelial cell line, 
LNCap, was mixed with collagen matrix and injected into the 3-D collagen gel to form a column 
of epithelial cells, which was visible in the culture plates (Figure 2.4C). After matrix 
polymerization and tissue culture, collagen gels containing the column were taken out for 
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histological analyses (Figure 2.4D). The apparent formation of the column structure is important 
to achieve our goal of building a desired structure in cell culture models. 
The histology of the tissue models at micron level can provide more detailed structural 
information. Therefore, the 3-D culture models were carefully formalin-fixed and paraffin-
embedded before being sectioned and submitted for microscopic analysis. The H&E image of 
tissue cross-sections (Figure 2.5A) showed a nicely structured circular column. Images at 
different depths showed the similar structure and indicated a well-constructed column.  
While structure formation is important, it is also essential to monitor the health of cells. 
The 3-D models were then further examined using a cell live/dead staining assay, where live 
cells show green fluorescence and dead cells are stained in red. The results of the images (Figure 
2.5B) clearly showed a well grown structure where epithelial cells and fibroblasts were co-
cultured and nicely organized. It is interesting that although epithelial cells were seeded in 
clusters at the beginning, they migrated away from the center and were shaped into a column 
after 3 days (Figure 2.5C, D). Overall, confocal images taken at different depths of the 3-D 
culture all indicated healthy cell growth.  What is more important is the formation of a lumen 
structure, which is one of the main goals of this study. Although it is still a relatively preliminary 
structure compared to natural prostate tissues, this tissue model resembles the important basic 
cellular organization of multiple cell types, and provides an interface for epithelial-stroma 
interactions, one of the most important features in cancer, which will be further discussed later. 
2.3.3 Bioreactor 
A novel 3-D microfabrication technology, projection micro-stereolithography (PµSL), 
developed by Professor Nicholas Fang’s group, was introduced for the fabrication of 
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vascularized micro bioreactors (Figure 2.6A). As we discussed earlier, conventional 3-D culture 
in ECM has inherent transport problem due to the limit of nutrient exchange. In addition to solve 
the mass transport problem, the vascular structure fabricated using this PµSL method also brings 
additional advantages to the field of tissue engineering. First, the micron scale capability of 
PµSL provides high spatial resolution of 3-D microstructures that is close to human tissues. 
Second, the time of building a desired 3-D structure can be shortened from days in conventional 
3-D culture to a few hours using PµSL. Third, the fabrication process gives us the full control of 
the final structures of the tissue constructs, instead of fully or partially relying on cells 
themselves to form the desired structures.  
A 3-D structure was first designed to mimic a glandular tissue like prostate (Figure 
2.6B,C). It is a hollow short cylinder with 19 capillaries connected to the bottom. The cylinder is 
2.5 mm in diameter and 1.5 mm in height. The fabrication is composed of 100 layers and it takes 
5 hours for each scaffold. The enclosed capillaries have inner diameter of 160 micro meters and 
outer diameter of 200 micro meters and they are 1 mm long. Scaffolds are kept in 99.5% acetone 
for 12 hours after fabrication in order to remove the residual monomer, initiator and UV absorber. 
Scaffolds are rinsed in buffer solution for at least 6 hours to remove acetone before cell culture. 
These bioreactors have lumen structures, mimicking the glandular nature of tissues like prostate. 
The fabricated bioreactor was imaged using electron microscopy, showing a clear vascular 
structure as designed (Figure 2.6D) and its micro-scale structure was also examined (Figure 
2.6E). 
Epithelial and fibroblast cells were seeded to two sides of the bioreactor, respectively. 
Fibroblasts filled the large chamber, resembling the stroma of tissues, while epithelial cells were 
grown along the walls inside the columns, resembling the functional epithelial layer of tissues. 
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They were cultured over a period of two weeks. Cell growth was monitored using light 
microscopy (Figure 2.7A, B). Epithelial cells were shown to be lined on the capillary walls, 
while fibroblasts grew well inside collagen matrix. These images indicated that the desired 
structures of the tissue constructs can be reasonably achieved using microfabricated bioreactors.  
The health of cells is also an essential factor, because these bioreactors are designed to solve the 
mass exchange problems in large tissue culture systems. Our results from the fluorescence 
live/dead assay showed that majority of the cells grew very well after 2 days of culture (Figure 
2.7C,D), indicating a sufficient supply of nutrition, oxygen and other factors that are otherwise 
not available in conventional thick tissue culture systems. 
In summary, we developed and evaluated a new cell culture system using microfabricated 
bioreactors. This system not only provides our desired lumen structures in the 3-D tissue models, 
but also solves mass transport problems that often exist in conventional large or thick 3-D cell 
culture systems. 
 
2.4 Conclusions 
Here, we present two tissue engineering methods in making 3-D cell culture tissue 
models. One is 3-D extracellular matrix culture, and the other is microfibricated bioreactor 
culture. While these are still ongoing efforts, our preliminary results in skin and prostate 3-D 
model development provide an important tool to study cellular microenvironment, one of the 
most essential aspects of tumor initiation and progression. We are not trying to build tissue 
models that can replace natural tissues in clinical applications. Instead, we develop these tissue 
models to study molecular dynamic changes in tissue model systems. 
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2.5 Figures 
 
Figure 2.1 Schematic of skin tissue engineering. (A) Human skin with various 
accessory structures. (B) Engineered skin without accessory structures. (C) Engineered 
skin is cultured at the air-media interface for full maturation. 
 
Figure 2.2 Tissue culture of engineered skin. (A) Picture of the cell culture hood. (B) 
Engineered skin tissues cultured in a 6-well place. (C). Picture of an individual 
engineered skin tissue. 
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Figure 2.3 Histology of engineered skin. (A) H&E staining image of a full-thickness 
engineered skin tissue. (B) Fully developed stratum corneum from an engineered full-
thickness skin tissue. (C) Melanoma tumor cell growth in an engineered melanoma 
tissue model. (D) Engineered melanoma tissues cultured for a period of 20 days. 
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Figure 2.4 Tissue engineering of a simplified prostate model. (A) Interconnecting glandular 
structure of prostate. (B) Schematic of the injection method to make a lumen structure in 3-
D culture. (C) A photograph of the column structure taken from bottom of culture dish. (D) 
A photograph of the column structure inside the 3-D cultured tissue. Red arrow shows the 
location of the lumen. 
 
Figure 2.5 Cell growth in the simplified prostate tissue model. (A) H&E image of the 
column structure in a cross-section of the tissue model. (B) Fluorescence image of co-
culture of epithelial and fibroblast cells in the tissue model. (C) Epithelial cells 8 hours 
after being seeded. (D) Epithelial cells 3 days after being seeded. 
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Figure 2.6 Bioreactor development using projection micro-stereolithography (PµSL). 
(A) Schematic of PµSL technology. (B, C) CAD design of a capillary bioreactor. (D) 
Electron microscopy image of the bioreactor. (E) Electron microscopy image of the 
polymer structure of the bioreactor. E: side for epithelial seeding; F: side for fibroblast 
seeding. 
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Figure 2.7 Cell culture in bioreactors. (A) A photograph of fibroblast side of a 
bioreactor. (B) A photograph of epithelial side of a bioreactor. (C) A photograph 
showing cells inside a bioreactor. (D) A fluorescence image showing live cells inside a 
bioreactor. E: epithelial cells; F: fibroblast cells. 
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CHAPTER 3 
DEVELOPMENT AND CHARACTERIZATION  
OF ENGINEERED SKIN TISSUE MODELS 
3.1 Introduction 
A majority of human cancers arise within the skin. Though melanoma comprises less 
than 4% of diagnosed skin cancers, it causes over 75% of skin cancer-related deaths and its 
incidence is rapidly increasing.1 Despite decades of scientific research, the sole effective cure is 
surgical excision of the primary tumor2 when the lesions are smaller than 1 mm.3 The prognosis 
for a patient with stage I or II melanoma is mainly related to tumor thickness. Hence, early 
detection is critical in melanoma treatment, and the evolution of the tumor and its penetration 
into the dermis are key factors to be studied in understanding the disease.4 Melanoma is a tumor 
of melanocytes, which are a class of cells located at the epidermal-dermal junction. Functionally, 
they interact with multiple keratinocytes to form an epidermal melanin unit. Hence, melanocytes 
are morphologically and functionally pre-disposed to multiple interactions with diverse cell types. 
These properties lead to two specific difficulties in the scientific study of melanoma progression: 
the first is that the location of the tumor and interactions with multiple cells5,6 makes behavior in 
traditional, two-dimensional cell culture less realistic. Observations in-situ are limited, however, 
and tumor progression cannot be followed in humans due to ethical concerns. Hence, appropriate 
model systems are needed. Second, the spatially-distributed nature of the tumor requires the use 
of imaging techniques but the influence of multiple cells requires biochemical contrast – 
especially to study subtle molecular changes in early stage disease and its progression.  
Two converging trends can now address these issues. The first is the development of 
model systems to study disease and the second is the development of new imaging technologies. 
Engineered tissue structures 7  are attracting increased interest as a surrogate for human 
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experiments. In particular, compared to traditional, two-dimensional (2D) cell cultures, 
engineered tissues provide a more realistic, three-dimensional (3D) and controllable model to 
study a variety of basic cellular processes.8 Their use in studying disease progression has also 
been proposed but is somewhat limited.9 Due to the precise structuring of the sample, engineered 
tissue models are also a convenient sample set for developing imaging technology. As opposed 
to geometrical phantoms, engineered tissues represent a more realistic biological subject10 while 
their simplified structure is often an acceptable surrogate for the less-accessible, variable and 
more complex human tissue. Among all human tissues, skin has a relatively simple, laminar 
structure that is naturally suited to tissue engineering. Consequently, much success has been 
achieved in engineering skin tissue,11 models are commercially available and have been used for 
a variety of research and therapeutic applications.12 
Imaging methods provide useful insight into tumor structure and its evolution and are 
actively being developed for clinical use in various modalities. Similarly, there have been efforts 
to characterize melanoma progression in biochemical terms,13including understanding the role of 
cells other than melanocytes in tumor evolution.14 While structural characterization of tissue and 
tissue models is routinely accomplished by structural imaging, a biochemical characterization 
typically requires destruction of the structure, thereby losing spatially specific information. A 
combination of biochemical and structural knowledge is often helpful and is enabled by the 
emerging fields of chemical imaging15 and microscopy. While molecular imaging is dye- or 
probe-based, chemical imaging holistically measures chemical species in the sample using 
spectroscopy. The desired information is then extracted using computational methods. Among 
the prominent approaches are vibrational spectroscopic, both Raman and infrared (IR), 
imaging.16Fourier transform IR (FT-IR) spectroscopic imaging17 is useful for the analysis of 
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tissue biopsies and has a well-developed instrumentation and data analysis knowledge 
base.18Recent compilations19describe biomedical applications, in general, and several reports 
specifically describe IR spectroscopic studies on human skin. The skin-focused reports 20 
examine the structure of skin, 21 , 22 , 23 , 24  diseases, 25 , 26 , 27 , 28 , 29  dynamics of 
diffusion30,31,32,33,34,35,36,37or use it as a model system for studies.38 There are no reports, to our 
knowledge, on analyzing engineered skin with IR spectroscopic imaging. Similarly, while tumor 
grades have been related to spectral signatures in the prostate for example,39 we are not aware of 
reports specifically examining tumor progression in a controlled environment. 
Here, we apply FT-IR imaging to study of melanoma progression in engineered skin. We 
systematically examine spectral and spatial properties of engineered skin with reference to 
measurements of human tissue, the spectral recognition of tumor and the changes in each cell 
type as a function of tumor progression. In particular, we examine the question of stromal 
involvement in melanoma progression. Though the concept was proposed almost 120 years 
ago, 40  facile methods to measure such a transformation are lacking. By examining both 
engineered skin and progression, we present new tools that will allow for quality control and 
standardization of both the structural and biochemical properties of engineered tissues, models to 
study disease progression and phantoms for imaging. 
 
3.2 Materials and Experiments 
3.2.1 Engineered Skin Culture 
Skin scaffolds (MatTek Inc.) consist of 8-10 layers of normal human epidermal 
keratinocytes grown on a 1mm think layer of normal human dermal fibroblasts seeded in 
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collagen gel, which was in turn supported by an inert polymer insert with 0.4 µm pore size. A 
malignant melanocyte cell line, A375, was mixed with and incorporated into the epidermal layer 
during cell seeding. The tissue was cultured in MCDB 153 serum free medium, which was 
renewed every two days. 
3.2.2 Engineered Skin Sample Preparation 
Each tissue sample was removed from the culture at a specified time and fixed with 10% 
neutral buffered formalin, followed by gradient dehydration in 70%, 95% and 100% ethanol. The 
sample was cleared with a 1:1 xylene/ethanol mixture and then with neat xylene. Subsequently, 
the sample was embedded in paraffin following standard histological procedure. Embedded 
tissue was sectioned to 5µm slice with a SHUR/Sharp™ 4060E Electronic Rotary Microtome 
(Triangle Biomedical Sciences) and placed on BaF2 substrates. 
3.2.3 Human Skin 
Human skin samples were obtained from Carle Foundation Hospital after institutional 
board review and appropriate anonymization of sources. Tissues were formalin-fixed and 
paraffin-embedded before being sectioned, following the same procedure for engineered skin 
samples. These samples were placed on low-e glass slides. 
3.2.4 Haematoxylin and Eosin Staining 
Tissues placed on slides were de-paraffinized using Xylene and were subsequently 
rehydrated using solutions of 100%, 95%, 70% Ethanol and deionized water. Slides were then 
stained with hematoxylin for 5 min and Eosin for 30 sec with subsequent dehydration in a series 
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of gradient Ethanol and Xylene. Images of stained tissues were acquired using a VWR Vista 
Vision inverted microscope. 
3.2.5 FT-IR Imaging: Data Acquisition and Processing 
Samples for IR imaging were placed on 1 mm thick BaF2substrates or low-e glass slides 
and dehydrated using hexane as previously described. 41  IR spectroscopic images of tissue 
sections were collected using the Perkin-Elmer Spotlight 400 imaging spectrometer. A spatial 
pixel size of 6.25 µm and a spectral resolution of 4 cm-1 were employed, with 4 scans averaged 
for each pixel over the entire mid-infrared range. An undersampling ratio of 2 with respect to the 
He-Ne laser was used in recording the interferogram. Norton-Beer medium apodization was 
employed with a zero fill factor of 2 during the Fourier transform. An IR background image was 
acquired with 120 scans co-added at a location on the substrate where no tissue was present. A 
ratio of the background to tissue spectra was then computed to remove substrate and air 
contributions to the spectral data. All further computation was done using programs written in-
house in ENVI/IDL. 
 
3.3 Results 
3.3.1 Structural and Spectral Comparisons of Human and Engineered Skin Tissues 
A comparison of the optical microscopy and IR data of human and engineered skin is 
shown in Figure 3.1. As apparent in the structural images, the engineered skin model has 
simplified structures with only two major layers – epidermis (including its associated stratum 
corneum structure) and dermis, without complicated multiple sub-layers and various other 
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histological sub-types seen in human skin (Figure 3.1A, B). Structurally, engineered and human 
skin have been shown to be similar in use42 and these simplified tissue models have retained 
many important skin functions. We compared both the structure and the spectral features of the 
common tissue sub-types between human and engineered skin. The FT-IR imaging data here 
indicate that the engineered tissues have preserved skin differentiation seen in human skin 
(Figure 3.1C), although there are small chemical composition differences likely due to the 
simplified structures and differences in cellular density and cell-cell interactions (Figure 3.1D) 
Characteristic IR absorption peaks in human skin have been reported in various 
studies.23,43,44,45 They have been summarized, as shown in Table 3.1, for the two major groups 
under consideration here. Each of the different histological structures in skin will have different 
distributions of various chemical constituents, namely the abundance and types of lipids, proteins, 
carbohydrates and nucleic acids. These differences will correspond to differences in specific 
spectral features, largely in the spectral fingerprint region. Here, we compared spectral features 
observed in engineered skin with those observed in human tissue in the context of their 
assignments as reported in the literature (Table 3.1). Notably, engineered skin samples differ in 
both intensity and position of spectral features (Figure 3.1C), indicating the abundance and 
environment of some biomolecules are likely different. There are also important histologic 
differences that make direct comparisons difficult, changes in immortalization of cell lines are 
probably influential and individual differences probably do exist. For example, the multiple-layer 
structure of epidermis is not present in engineered skin samples, although stratum corneum, the 
outmost layer, is indeed developed over the time (Figure 3.1B). Notably, many important 
spectral features are still observed in engineered skin as listed in the table. In summary, 
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spectroscopically, engineered skin is different from tissue derived from humans but is reasonably 
representative of the spectral properties of skin.   
3.3.2 Characterization of Melanoma Engineered Tissue Model 
We engineered skin samples with malignant melanocytes as described in the methods 
section.  Samples were removed and analyzed every fourth day for a total time period of 28 days. 
Two consecutive 5 µm tissue sections were used for HE staining and FT-IR imaging, 
respectively. We observed that tumors were limited to small cell clusters at the beginning of the 
experiment, but grew larger and deeper into the tissue over the time (Figure 3.2). Tumors can be 
tracked in absorbance images and classifiers for the same could be developed following previous 
methods in automating histological recognition.41 In this case, however, we can readily identify 
the tumor by differential absorption and are more interested in following the evolution of the 
tumor and tissue over time.  
3.3.3 Stability and Consistency of Melanoma Engineered Skin Model 
To determine the stability of these engineered structures for spectroscopic analyses, we 
examined the temporal variation of spectra for “normal stroma” or dermal regions at least 500 
µm away from tumors. 100 representative pixels from normal stroma were extracted from each 
of the eight samples (Figure 3.3A, B). We employed a recently proposed visualization and 
statistical analysis tool, termed Comprehensive Data Map (CDM),46 to analyze spectral variation 
among these pixels (Figure 3.3C). Briefly, CDM provides a convenient method of graphically 
displaying data so as to convey the view of signal and variance and identify patterns and trends 
in complex datasets. The data are mean centered using an average for the entire data set and the 
average spectrum is shown above the data. The central data block consists of rows of spectra, 
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with each row having a particular set of data associated with it. The display is the difference 
from the average. The spectral regions at which differences occur are apparent from the color 
display in the figure. It appears that differences are primarily concentrated at large absorbance 
areas (amide I, amide II and amide A peaks). While there are also differences at characteristic 
spectral regions, such as the fingerprint region among some of the samples, these differences are 
quite small, even after we changed the way CDM presents the differences by normalizing them 
to the magnitude of the average spectrum (data not shown). In addition, these differences do not 
appear to have any particular patterns. These results indicate that the skin samples are quite 
consistent for our infrared spectroscopic imaging analysis, which primarily utilizes the 
information from those characteristic spectral regions. A measure of the biologic noise, hence, is 
the standard deviation in time. 
Next, we examined the spectral variation of tumor pixels during the course of melanoma 
invasion starting from day 8 (Figure 3.3A, B). No changes were observed that could be related to 
the time course of invasion, which is also confirmed by CDM analysis (data not shown). The 
inability of IR spectroscopy to capture these changes could arise from insufficient sensitivity of 
the technique or experimental limitations, for example in the signal to noise ratio.47 We believe, 
however, that the consistency in spectra likely arises from the biological basis of these cells in 
culture. The cells likely obtain their proliferative capacity prior to culture and are not modified 
considerably by the culturing environment or process. It is likely that melanocytes in engineered 
skin have previously experienced interactions with both epidermal and dermal cells in tissue and 
likely do not transform in the new milieu of the engineered tissue. In either case, there is no 
apparent signature in the tumor cells that correlate with tumor progression. To understand 
transformations associated with malignancy, hence, a comparative analysis of benign and 
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malignant cells is desirable but beyond the scope of the manuscript here. Studies have previously 
reported melanoma analysis using IR spectroscopy,26,48,49,50,51,52,53 but, to our knowledge, have 
not examined the spectral properties as a function of tumor progression. 
3.3.4 Identification of Tumor and Stroma interactions in Engineered Melanoma Model 
While changes in tumor cells are one aspect of progression, interactions between the 
tumor and its microenvironment is another important and rapidly emerging aspect of 
understanding tumor evolution.54,55 Here, we hypothesize that cells that are in close contact with 
tumor may possibly undergo spectral changes that reflect the underlying change of biomolecular 
expression. Since it is difficult to postulate every change a priori, a holistic method of measuring 
changes is likely useful. Hence, we employed FT-IR imaging here to probe the stromal regions 
surrounding tumors at different time points (Figure 3.4A). Two stromal regions – one closely 
associated with the tumor in the vicinity of 10-100 µm and the other at least 500 µm away – are 
identified as tumor associated stroma and normal stroma respectively. Average spectra from 
these two regions were obtained and compared (Figure 3.4B). One of the most significant 
variations over the time occurs at the fingerprint region, especially from 1200-1300 cm-1(Figure 
3.4C). This region is closely associated with the proteins of the connective tissue and extra-
cellular matrix. Hence, the changes likely indicate a matrix remodeling rather than large scale 
changes in stromal cells. Further, the change appears to start between day 12 and day 16, 
corresponding to the histological observation that tumor invasion becomes apparent around day 
12. Therefore, the spectra from regions next to tumor appear to have undergone a transition due 
to the tumor development, suggesting the possibility of heterotypic interactions and 
transformations in engineered tissue. It is notable that the biochemical changes do not appear to 
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precede the histological changes. Hence, the methods we have used do not appear to be sensitive 
to biochemical changes preceding apparent morphological changes, if such are present. 
3.3.5 Studies of “Field Effect” of Tumor-stroma Interactions in Melanoma Model 
This change in stromal characteristics is also known as “field effect” for many other 
tumors 56 , 57 .While field effect changes are histologically hard to differentiate, the chemical 
change is seemingly well-suited to analysis by FT-IR imaging. To validate that we are indeed 
observing the field effect, we sought to examine the spatial dependence of stromal 
transformation. Regions of interest close to the tumor and from progressively increasing distance 
were analyzed. Seven spatial regions adjacent to the tumor (Figure 3.5A, indicated by R1 
through R7) are chosen and average spectra of these seven regions of interest (ROIs) are 
compared to the average spectrum from the tumor (Figure 3.5B). While average spectra are 
useful, visualization of changes and the relative importance of changes are difficult to appreciate. 
To facilitate the identification of specific spectral regions that undergo transformations, we 
employed the CDM tool again to show the variation among these ROIs (Figure 3.5C). The 
difference of each spectrum in a few regions from the mean spectra, including a prominent peak 
from 1200-1300 cm-1 clearly shows a trend of transition from tumor to distal stromal regions. 
Same conclusion can be drawn from the analysis of ROI regions (R’1-R’7) obtained from a 45° 
angle. 
The map indicates several regions corresponding to the transformation. The first region is 
between 2800-3000 cm-1, which arises from various C-H stretching vibrational modes (Figure 
3.5C). The most interesting changes, however, are those in fingerprint region, including peaks in 
the 1430-1480 cm-1 range arising from CH2 scissoring modes, 1330-1360 cm-1 attributed to CH2 
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wagging modes, and the protein specific-peaks at 1200-1300 cm-1 that also differ significantly at 
the surrounding stromal regions over the course of tumor invasion as we discussed above (Table 
3.1). This tri-peak spectral region is often confused with features from nucleic acids, which are 
located in the similar region. Here, the lack of nuclear density and abundance of collagen in the 
extra-cellular matrix indicate that these features likely arise from collagen’s C–N stretching and 
in-plane bending modes.45 The regions close to the tumor appear to have adopted certain level 
of similarity to the neighboring tumors, while this similarity diminishes when the region is 
further away. While this may indicate a mesenchymal-to-epithelial type of transformation, we 
caution that the interpretation of results is made difficult by the lack of specific molecular 
features indicative of such a transformation. What is apparent is that the effect extends over a 
distance of 50-100 µm. Hence, spectroscopic imaging presents an attractive means to 
determining holistic chemical changes,58 which can then be further probed for molecular details 
by other modalities. 
Similar results are observed in samples with other tumors in which the tumor is large 
enough to be identified, namely from days 20, 24 and 28. We especially focused on the collagen-
specific region (1200-1300 cm-1) as it offers an interpretation of the field effect for our 
measurement. Similar to above studies, spectra from tumor and 7 neighboring regions are plotted 
(Figure 3.6A). Spectra from regions next to tumor are distinct from either tumor or stroma, and 
appear as a transition between tumor and benign stroma in the distal region, suggesting the 
possibility of heterotypic interactions and transformations in engineered tissue. CDM was also 
used to visualize the variance of the spectra, giving the same 4 regions of transition we saw 
earlier (Figure 3.6B). The trend demonstrated is consistent with the biological understanding of 
collagen, the major component of extracellular matrix, being biochemically remodeled59 and 
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eventually occupied by invading tumor cells. 60  As a result, the spectral contributions from 
collagen cross-linking diminish closer to the tumor and likely diminish over the time prior to 
tumor invasion. The most interesting observation here is that this type of transition appears to 
occur over a region much larger than the dimension of a single tumor cell, for example. Further, 
this chemical change appears to have begun before changes that are apparent in traditional 
histological methods, which might be critical for early tumor detection and treatment. The effect 
seems to be limited to 50-100 µm close to the tumor. We must emphasize that this is a molecular 
measure of the “field effect” as opposed to prior studies using histological57, optical61 or specific 
gene/protein62 measure of the effect. Reconciling the various data on model systems, such as the 
ones proposed here, would likely prove beneficial. Finally, the measurements here are still 2D-
histological analyses of a 3D tumor. Methods to study tumor growth in 3D using non-invasive 
imaging techniques will likely prove useful. Heterotypic interactions between malignant and 
benign tissues are an important component of tumor progression. By identifying and localizing 
this aspect in the model system, detailed molecular studies of these interactions can now be 
performed. Stromal-epithelial interactions present an emerging and promising approach to 
control tumor growth. Hence, the combination of model disease systems in culture and holistic 
methods of analysis, such as FT-IR spectroscopic imaging, can provide valuable research and 
clinical information. This study is a step towards that direction by presenting a framework for 
analysis and evidence for stromal involvement in tumors. 
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3.4 Conclusions 
We present here the rationale and a preliminary analysis of a melanoma model in 
engineered skin using FT-IR spectroscopic imaging. The technique allowed for rapid 
visualization of skin constituents and tumors induced within without the use of stains or dyes. 
We then conducted numerical analysis to demonstrate that the tumor cells demonstrated stable 
spectral profiles over time. Using comparative spectral profiles, we determined that the stroma 
was remodeled around a tumor in the 50-100 µm vicinity. The study presents a novel tool for 
various applications. It provides the cancer research community with a powerful analytical tool 
to characterize the extent of tumor influence, presents the spectroscopy community access to 
model systems for studying cancer progression, provides a platform for the chemometrics 
community to develop better tools and algorithms in cancer research by providing longitudinal 
samples and, finally, the tissue engineering community in measure holistic chemical changes 
during the development and maturation of samples. 
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3.5 Figures 
 
Figure 3.1 Skin structure and characterizations. (A) Schematic of human (left) and 
engineered skin (right). The epidermis is located at the skin-air interface while the 
dermis is located to the bottom of the image and contains various histologic 
structures. Engineered skin retains the most important components but doesnot 
contain accessory structures. (B) Histology of skin is usually deduced manually in 
tissue stained by Haematoxylin and Eosin (H&E). Epidermis typically stains 
darker than dermis. (C) Infrared absorbance image froma corresponding serial 
section of the tissue at 1660 cm-1.Human skin was imaged on a low-e slide in 
reflectance mode, and engineered skin was imaged on a BaF2 substrate in 
transmission mode. (D) IR spectra of single pixels from epidermis, dermis and 
stratum corneum regions of human and engineered skin after piecewise linear 
baseline subtraction. 
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Figure 3.2 Melanoma progression in 28 days. Tumors (arrows) grow larger and 
invade into the dermis over time, as shown by both H&E-stains followed by 
histological recognition and IR spectroscopic imaging. IR absorbance images at 
1660 cm-1 and 1284 cm-1 highlight epidermal and dermal regions, respectively, 
indicating different chemical compositions between these two regions and their 
facile delineation by simple spectral metrics. 
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Figure 3.3 Temporal analysis of tumor and normal stroma. (A) Spectra of 10 pixels 
of tumors (green arrow) and 10 × 10 pixels of normal stroma that are at least 500 
µm away from tumors (blue square) are extracted for temporal analysis. (B) 
Comparison of average spectra from tumor and normal stroma regions. (C) CDM 
visualization of spectra of normal stroma. The average spectrum is shown above 
the data and the central data block displays the difference of each pixel spectrum 
from the average spectrum.  
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Figure 3.4  Temporal behavior of normal and tumor-associated stroma. (A) 
Spectral regions of tumor (red circle) and tumor associated stroma are extracted for 
analysis of temporal changes. (B) Spectral analysis of normal and tumor-associated 
stroma demonstrates likely differences between the two, especially including 
significant changes in the 1200-1300 cm-1 (blue circle) region. (C) Spectral detail 
of the 1200-1300 cm-1 region indicates that the biochemical changes likely occur 
around day 16. 
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Figure 3.5Analysis of stromal transformation around a tumor. (A) Spectra at 
tumor-neighboring dermal region at different depths and angles (R1-R7, R’1-R’7) 
are extracted. (B)Analysis of ROIs from the tumor and 7 peritumoral regions at 
both angles shows spectral differences. (C) CDM suggests a transition pattern of 
spectra from tumor to distal stromal regions at a few spectral peaks (highlighted by 
boxes in the picture), including a prominent peak 1200-1300 cm-1 (red box).A 
sample from day 20 is used for the analysis. 
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Figure 3.6 Chemical analysis of melanoma-stromal interactions. Regions of 
interest are extracted from tumors and from progressively increasing distance in 
stroma(R1-R7). Two duplicate dsamples from day 20, 24 and 28 are used. (A) The 
spectral regionof 1200-1300 cm-1, corresponding to collagen specific peaks,is 
presented to show the magnitude of changes. (B) CDM is used to visualize the 
differences among spectra. Regions of transition are highlighted in squares, 
including the collagen region (red square). 
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3.6 Tables 
Table 3.1 Assignment of IR spectral features in skin. Results are reported from 
compilations in the literature43,44,45 and from analysis of this study’s skin samples, 
including both clinical and engineered tissue.  
 
 
 
  
Mode Origin Literature Human Skin Engineered SkinEpidermis Dermis Epidermis Dermis
Amide A (N–H stretching) Peptide, protein 3300 3298 3298 3292 3292
Amide B (N–H stretching) Peptide, protein 3080 3078 3078 3080 3082
C–H stretching of alkenes 
Phospholipid, glycolipid, fatty acid, 
ceramide, triglyceride 3010 3010 3010 3012 3012
Asymmetric CH3 stretching 
Phospholipid, glycolipid, fatty acid, 
ceramide, triglyceride 2957 2960 2960 2962 2958
Asymmetric CH2 stretching 
Phospholipid, glycolipid, fatty acid, 
ceramide, triglyceride 2920 2920 2920 2916 2918
Symmetric CH3 stretching 
Phospholipid, glycolipid, fatty acid, 
ceramide, triglyceride 2872 2868 2868 2874 2874
Symmetric CH2 stretching 
Phospholipid, glycolipid, fatty acid, 
ceramide, triglyceride 2851 2850 2850 2850 2850
CO stretch Phospholipid 1738 1740 1740 1738 1738
Amide I (80% CO stretch) Peptide, protein, ceramide 1655 1654 1654 1664 1664
Amide II (60% N–H in plane bend, 
40% C–N stretch) Peptide, protein, ceramide 1545 1548 1548 1552 1550
CH2 scissoring 
Phospholipid, glycolipid, fatty acid, 
triglyceride 1468 1468 1468 1454 1460
CO stretch of COO– Fatty acid ~1395 1400 1400 1402 1392
CH3 symmetric bend Phospholipid, fatty acid, triglyceride 1378 1384 1384 1392 1390
CH2 wagging Phospholipid, fatty acid, triglyceride 1343-1370 1344 1338 1344 1336
Amide III (40% C–N stretch, 30% N–H 
in plane bend, 20% methyl–C stretch) Collagen 1283 1284 1284 1284 1284
Asymmetric PO2– stretch 
Phosphate salt, nucleic acid, DNA, 
RNA ~1245 1242 1240 1240 1238
Amide III (40% C–N stretch, 30% N–H 
in plane bend, 20% methyl–C stretch) Collagen 1236 1236 1234 1236 1236
Asymmetric PO2– stretch 
Phosphate salt, nucleic acid, DNA, 
RNA 1223 1224 1226 1224 1226
Amide III (40% C–N stretch, 30% N–H 
in plane bend, 20% methyl–C stretch) Collagen 1204 1204 1204 1204 1204
Ester C–O asymmetric stretch Ester 1170 1170 1168 1160 1170
Symmetric PO2– stretch 
Phosphate salt, nucleic acid, DNA, 
RNA ~1080 1082 1082 1082 1082
C–OP stretch Phosphate ester 1047 1056 1058 1034 1030
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CHAPTER 4  
CELL-MICROENVIRONMENT INTERACTIONS 
IN 2-D AND 3-D CULTURE SYSTEMS 
4.1 Introduction 
As we have discussed in earlier chapters, 3-D culture is a promising new tool for our 
understanding of biological and cellular processes. Our current studies of many of those 
processes are largely based on cells cultured on flat 2-D plastic or glass substrates. However, 
cells primarily live inside a complex cellular microenvironment that consists of extracellular 
matrix (ECM) components, rich signals for cell-cell interactions and various other soluble and 
insoluble factors.1,2,3 Although the simplicity of 2-D culture has provided reductionist approaches 
to understand complex cellular processes, many of these findings might not faithfully capture the 
physiological behavior of cells in vivo.4,5,6,7 Therefore, it is increasing popular to develop more 
realistic 3-D cell culture, as we have shown in the earlier chapters.  
However, we must be careful not to oversimplify the comparisons of the 2-D and 3-D 
results into a single difference of dimensionality without specifying what factors contribute to 
the potential differences between 2-D and 3-D culture. Cellular microenvironment is generally 
believed to include soluble factors like growth factors and insoluble factors like mechanical 
signals.1 Therefore, we will look at the influence of some of those factors using both 2-D and 3-
D cell cultures systems in our lab. 
4.1.1 Transforming Growth Factor β - An Example of Soluble Factors  
Soluble factors in microenvironment include primarily growth factors, cytokines, and 
nutrition. They are important in regulating cell behaviors and are an essential part of tumor 
initiation and progression.8,9,10,11  A few growth factors are among the soluble factors that have 
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been identified. For example, vascular endothelial growth factor (VEGF) was reported to be 
androgen regulated and it can stimulate the angiogenesis in prostatic hyperplasia. Other soluble 
factors include interleukin-6 (IL-6), insulin-like transforming growth factor β (TGF-β), growth 
factor-I (IGF-1), and keratinocyte growth factor (KGF) among others. We will focus on TGF-β1 
in our studies. 
Transforming growth factor-βs (TGF-βs) play a dual role in cancer development.12 In 
normal tissues and during early stages of cancer, their suppressor activities are dominant. In 
contrast, during advanced stages of cancer development, TGF-βs favor the oncogenic activities 
to promote tumor development and metastasis.2,13  Both the tumor suppressor and oncogenic 
activities of TGF-βs are achieved through the tumor microenvironment. During tumorigenesis, it 
is generally accompanied by a decreased responsiveness of the tumor cell to tumor suppressors, 
coupled with an increased production of TGF-βs, which may promote oncogenic effects on 
stromal elements.14,15 In carcinomas, the amount and composition of stroma are partly dependent 
on the response of fibroblasts to the growth factors secreted by the cancer cells such as TGF-βs, 
platelet-derived growth factor (PDGF) and fibroblast growth factor 2 (FGF2), which are all key 
regulators of fibroblast activation and tissue fibrosis.16 Studies have shown that the conversion of 
fibroblasts into myofibroblasts is the most prominent stromal reaction in many carcinomas.17,18,19 
During this process, fibroblasts are activated and become myofibroblasts, which are 
characterized by the expression of their marker protein, α-smooth muscle actin (α-SMA). The 
myofibroblasts are considered to be associated with the tumors at all stages 2 and tumor-induced 
fibroblasts-to-myofibroblasts conversion further promotes neoplastic  progression and 
myofibroblasts invasion.20,21,22,23 We will monitor the SMA marker as the indication of fibroblast 
transformation upon the stimulation of TGF-β1. 
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4.1.2 Mechanical Stress on Cells - An Example of Insoluble Factors  
In recent years people came to appreciate that insoluble factors are as important as 
soluble factors in cellular microenvironment. 24 , 25 , 26  Of all the insoluble factors, the 
mechanobiological signals are among the most important for the cellular activities.27,28,29,30 For 
instance, cells in organs and tissues are constantly experiencing physical force such as 
compressive or tensile stress, therefore cells often adapt to the dynamical mechanical 
environment and consequently modulate their cellular properties in response to the applied 
force.31 Studies of the effect of mechanical stress on cells can contribute to understanding of cell-
microenvironment interactions. 
Here, we will focus on one aspect of the mechanobiological pathways, the influence of 
mechanical stress on cell-cell binding strength. Cell-cell interactions in multicellular structures 
are largely guided by adhesions formed both between neighboring cells and between cells and 
the ECM.32,33 People used to believe those cell-cell interactions only play a passive role in 
maintaining cell attachment and resisting external forces, but it is now becoming increasingly 
evident that they also actively participate in transmission of forces between cells.34 
In multicellular structures, such as epithelial monolayers, cells form adhesions to 
neighboring cells primarily through cadherin-mediated adhesions, as well as to the extracellular 
matrix. It is known that cadherin-mediated adhesions to neighboring cells depend on applied 
force and the accompanied signals.35 These adhesions also have the potential to sustain large 
tensile loads. 36,37 
Cadherins superfamily is a large superfamily of calcium-dependent cell adhesion proteins. 
They are known to play a major role in development and tissue morphogenesis.38 The cadherin 
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superfamily consists of the “classical” cadherins, protocadherins, desmosomal cadherins, and 
other cadherin-like proteins. Among them the “classical” cadherins are the most well studied and 
they are often named according to the tissues from which they were first identified. For example, 
E-, N-, and R-cadherins were derived from epithelial, neural, and retinal tissues, respectively, 
although we now know their expressions are often not limited exclusively to these tissues.39 
Among all cadherin proteins of the cadherin family, E-cadherin is the most well-studied, and 
various reports indicate that it is an important link between the mechanical force and 
corresponding cellular processes.40,41,42 
Here, we demonstrate a controlled application of mechanical stress over large area of a 
cell layer and quantification of its consequences using E-cadherin as a biomarker. 
 
4.2 Materials and Experiments 
4.2.1 Cell Culture  
Fibroblast cell line MRC-5 and epithelial cell line LNCap (American Type Culture 
Collection, Rockville, MD) were grown in both 2-D and 3-D culture systems using the same 
procedures described in Chapter 2. 
Cell culture within the stretching device system was based on new protocols we 
developed. Briefly, cells were cultured on an elastic substrates and the effect of mechanical stress 
on cell-cell interaction was carefully monitored. A polydimethylsiloxane (PDMS) film of 200 
µm thick was prepared and coated with poly-L-lysine solution to promote cell adhesion. Then the 
coated film was clamped on the both sides of the stretching device. The film was stretched up to 
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1.5 times (24 mm) of its original length (16 mm). LNCap cells were seeded on the film at the 
beginning seeding density of 40,000 cells/cm2. Cells were cultured for 2 days to form a relatively 
closely packed monolayer of cells. Then strain was relaxed at a constant rate of 1mm/hr for 8 
hours, resulting in restoration of the original length of the film (16 mm), which corresponds to 
application of 33% compressive strain to cells. For control experiment, cells were cultured on the 
unstretched PDMS film during the entire process. 
4.2.2 Biochemistry and Cellular Assays 
Immunocytochemical staining (ICC) and immunofluorescence staining (IHC) followed 
the same protocol described in Chapter 2 with some modifications due to the fact that cells were 
grown on polymer films. In this case, E-cadherin was immunostained as a marker of cell-cell 
junction formation. Other biochemistry and cellular assays, including live/dead cells assay, H&E 
staining, Western blotting, etc., all followed the protocols described in Chapter 2. 
4.2.3 Image Analysis of E-cadherin Expression 
In digital images, light intensity or brightness is represented in intensity count, a number 
ranging from 0 to 255 with 255 being the brightest. A threshold value of E-cadherin expression 
was determined to eliminate the background E-cadherin. Therefore, only relatively bright E-
cadherin expression was left, representing the mostly concentrated expression on the cell-cell 
junctions. Intensity count over the entire image was added up and divided by the number of cells 
which could be counted from the number of stained nuclei. This value was then a quantitative 
representation of E-cadherin involved in cell-cell bonding per cell. 
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4. 3 Results 
4.3.1 Response of Monolayer Cultured Fibroblasts to TGF-β1 Stimulation 
Cell responses to TGF-β1 stimulation in 2-D culture environment were first tested. 
Fibroblasts activation upon TGF-β1 stimulation was characterized by its conversion to 
myofibroblasts and the expression of α-SMA marker protein. Immunocytochemical staining of 
cells grown on glass bottom dishes showed a significantly increased level of α-SMA protein 
expression (Figure 4.1A). Immunofluorescence staining indicated the same results of increased 
α-SMA protein expression (Figure 4.1B). This was further confirmed by Western blotting, a 
more quantitative assay (Figure 4.1C). All these assays demonstrated that expression level of α-
SMA is significantly increased with TGF-β1 stimulation. This is consistent with what has been 
well understood about the process. Different concentrations of TGF-β1 were also applied to the 
cell culture, and there was an increase of cell response when the TGF-β1 was raised but not to 
the level of oversaturation43. Overall, these results confirmed that fibroblasts can be activated by 
TGF-β1 in our cell culture system. 
4.3.2 Response of 3-D Cultured Fibroblasts to TGF-β1 Stimulation 
A 3-D cell culture system was build (Figure 4.2A) using MRC-5 fibroblasts and collagen 
as the scaffold. Cells grew inside the collagen gel and started to contract and shrink the gel after 
2 days of culture (Figure 4.2B). A live/dead assay was used to monitor the cell viability inside 
the 3-D culture (Figure 4.2C). About 95% of cells were alive after 2 days of culture, indicating a 
healthy cell growth environment. The confocal fluorescence images from live/dead assay 
captured at different depths of the gel were reconstructed to form a 3-D image (Figure 4.2D), 
showing cell growth in our 3-D cell culture system.  
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Since TGF-β1 was shown to be able to transform the fibroblasts to myofibroblasts in 2-D 
culture in the above studies, it is interesting to see if it also works in 3-D culture. TGF-β1 was 
applied to our 3-D cell culture system and the histology of the 3-D cell culture with and without 
the growth factor stimulation was compared using H&E staining (Figure 4.3A). The results 
indicated that cells were more stretched in stimulated culture than those in control culture, which 
is consistent with the fact that myofibroblasts express high level of smooth muscle actin and 
therefore tend to generate greater cell contraction. To confirm that there was indeed an increase 
of α-SMA expression, fluorescence staining of α-SMA was conducted in the 3-D culture (Figure 
4.3B). Our results showed a high level of α-SMA expression in stimulated 3-D cell culture, while 
only very weak expression was observed in the non-stimulated control sample. β-actin is an 
ubiquitous component of cell structure and its abundance is generally considered to be constant 
across different cells. Hence, β-actin was stained as an internal control to eliminate any possible 
bias in cell number or density. The similar level of β-actin expression in both stimulated and 
control samples suggested that the α-SMA expression level is indeed significantly raised upon 
the stimulation of TGF-β1. Closer look at the cells under 10x and 63x objectives of the 
fluorescence microscope showed the apparent influence of TGF-β1 on fibroblast transformation 
(Figure 4.4A). The Western blotting results confirmed the levels of α-SMA (Figure 4.4B). 
In summary, similar to cellular responses in 2-D culture, fibroblasts also show the ability 
to transform into myofibroblasts upon TGF-β1 stimulation in 3-D. The difference of responses at 
these two different cell culture conditions is an interesting topic, and the work done by Jing Xu, 
who was also a member of our research group, has indicated that the stimulation is less 
prominent in 3-D culture and is capped by a certain dosage level.43 This is partly due to the fact 
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that our 3-D cell culture is a diffusion-limited system, and the consideration of diffusion is 
essential when utilizing 3-D culture system to study soluble factors. 44 
4.3.3 Cellular Response to Conditions of Growing Surfaces 
Cell growth in 2-D culture is known to depend on the surface properties. PDMS is a 
common polymer material and processes good elasticity, making it a good candidate for 
stretching test, which will be used in the next section. Cells do not attach or grow well on PDMS 
polymer. Hence, several surface treatment methods were tested, including poly-lysine coating, 
plasma treatment and UV-treatment. Results from a coating of poly-lysine on polystyrene dishes 
showed a more even coverage of cell growth on the surface (Figure 4.5A), indicating the ability 
of poly-lysine to help cell attachment and growth.  Similarly, cells attached and grew well on 
poly-lysine coated PDMS films, while very few cells grew on untreated PDMS films (Figure 
4.5B). Plasma and UV treatments, two of the other common surface modification methods, 
didn’t introduce any significant change in cell attachment and growth (data not shown). Overall, 
we showed that cells can grow well on poly-lysine coated PDMS films. Therefore, poly-lysine 
coating was chosen for our studies in the next section. 
4.3.4 Cellular Response to Mechanical Stress 
To study the changes in cell-cell interactions resulting from applied mechanical stress, a 
stretching device was developed in collaboration with Professor Nicholas Fang’s group. This 
device is designed to control the stretching of an elastic substrate on which cells are cultured. 
This device system consists of a motor, a reduction gear with 20:1 reduction ratio, a power 
supply, and the stretcher (Figure 4.6). The motor is connected to the stretcher through the 
reduction gear. The stretching rate of the device can be tuned from 1mm/hr to 80 mm/hr. The 
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stretcher has two clamp blocks on both sides. One close to the motor is fixed, whereas the other 
is actuated by the motor and moves laterally, thereby changing the distance between two clamp 
blocks and stretching or relaxing the clamped polymer films. The stretcher sits inside a culture 
dish, so that a film remains completely immersed in culture medium during the operation for cell 
growth. 
Stress was applied to cells as described in the Methods section. The resulting changes in 
E-cadherin expression on the cell-cell boundaries were used as an indication of cell-cell binding. 
Because E-cadherin is constantly expressed and distributed around the cells even if there is no 
cell-cell junctions, this “background” expression need to be distinguished from the actual change 
that comes from cell-cell interactions. The image analysis method is shown in Figure 4.7, and the 
details have been described in the Methods section. Briefly, the intensity of the E-cadherin 
expression, as well as the cell number, is digitized from the fluorescence images. A threshold is 
used to mask the “background” E-cadherin expression. The E-cadherin expression level can then 
be calculated. 
In this study, strain was applied to cells at a rate of 4% strain per hour (Figure 4.8A). Cell 
density on stressed film was about twice as high as that on the non-stressed film due to the 
squeezing effect (Figure 4.8B). E-cadherin per cell is the total intensity count per cell, indicating 
the overall level of E-cadherin in cells since there is no threshold. Concentrated E-cadherin is a 
parameter that we used to represent the E-cadherin on the cell-cell boundaries when a threshold 
of 128 is used (Figure 4.8C). The value of concentrated E-cadherin was about 45 times higher in 
stressed cells than that of non-stressed cells. This was significantly higher than the 2 times 
difference in overall E-cadherin levels. These results suggested that compressive stress greatly 
enhances cell-cell junction formation. 
74 
 
Overall, we have developed a device that can apply mechanical stress on cells grown on 
elastic polymer films. The compressive mechanical stress controlled by this device not only 
changes the morphology of cells, but also significantly enhances cell-cell junction formation as 
indicated by the concentrated E-cadherin expression.  
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4.4 Figures 
 
 
Figure 4.1 Response of monolayer cultured fibroblasts to TGF-β1 stimulation. (A) 
Microscopy images of cells with immunocytochemical staining (20×). α-SMAis shown 
in brown; (B) Confocal fluorescence microscopy images of cells with 
immunofluorescence staining (20×).  α-SMA is shown in green. (C) SDS-PAGE 
analysis of monolayer cultured fibroblasts.  Lane 1, MW marker; Lane 2, diffusate of 
cells w/o TGF-β1 stimulation; Lane 3, diffusate of cells w/ TGF-β1 stimulation. The 
result showed that there was same amount actin in the diffusates w/ and w/o TGF-β1 
stimulation. (D) Western blotting analysis of monolayer cultured fibroblasts. It showed 
that the amount of α-SMA in the sample w/ TGF-β1 stimulation was much higher than 
it in the sample w/o TGF-β1 stimulation. 
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Figure 4.2 The 3-D culture system used in this study. (A) A 3-D cell culture system. (B) 
An autograph of collagen gel in 3-D culture. (C) Live/dead assay showing cell growth. 
Green: live cells. Red: dead cells. (D) Reconstructed 3-D image from live/dead assay of 
the 3-D cell culture system. 
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Figure 4.3 Cellular responses to TGF-β1 stimulation in 3-D culture. (A) Histology of 
the 3-D cell culture sample with TGF-β1 stimulation showed a different morphology 
from the sample without stimulation. (B) Immunostaining results showed differential 
expression of α-SMA, a marker for fibroblast to myofibroblast transformation. β-actin 
staining showed the entire cell population. 
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Figure 4.4 Comparison of fibroblast transformation. (A) Cells expressing α-SMA 
marker proteins were observed using 10x and 63x objectives of the microscope. (B) 
Western blotting showed increased expression level of α-SMA but not β-actin. 
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Figure 4.5 Cell growth on treated polymer surfaces. (A) Cell growth on polystyrene 
surface of petri dishes w/ and w/o poly-lysine coating. (B) Cell growth on PDMS films 
w/ and w/o poly-lysine coating. 
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Figure 4.6 The stretching device used to apply stress to cells. This device system 
consists of a motor, a reduction gear, a power supply, and the stretcher. It can 
change the distance between two clamp blocks, therefore stretching or relaxing the 
clamped polymer films and regulating the strain on cells. The stretcher sits inside 
the culture medium in a culture dish, and is left in a cell incubator for cell growth. 
 
Figure 4.7 Schematic of the image analysis of E-cadherin expression. Fluorescence 
images from two channels (nuclei and E-cadherin) are analyzed from total cell number 
and E-cadherin expression, respectively. A threshold is selected to leave out the 
“background” expression that does not come from the influence of mechanical stress.  
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Figure 4.8 Compressive stress promotes E-cadherin expression in cell-cell junctions. 
(A) Fluorescence images indicated the E-cadherin expression in green and cell nuclei 
in blue. (B) Cell density, total E-cadherin per cell and concentrated E-cadherin per 
cell were plotted and compared. The concentrated E-cadherin expression at cell-cell 
junctions was increased by 45 times, while the total E-cadherin was merely increase 2 
times. This indicated the influence of stress on the E-cadherin expression and cell-cell 
junction formation. 
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CHAPTER 5 
CHARACTERIZATION OF PORCINE SKIN AS A MODEL 
FOR HUMAN SKIN STUDIES 
5.1 Introduction 
Skin is a naturally efficient barrier that protects the body from physical and chemical 
hazards, and the loss of water.1,2,3 Maintenance of the disease-free function of this vital organ is 
directly relevant in patients’ health and their social interactions. In particular, skin cancer is the 
most common form of cancer in the United States4 and the understanding of this tissue is of great 
importance to prevent and treat this disease. Skin is also an important pathway for drug delivery 
and for the application of cosmetics. Transdermal drug delivery has many advantages, such as its 
easy handling, safety, ability of controlled release and by passing gastrointestinal tract.5,6,7,8The 
combined needs in these areas have led to the development and use of several model systems as 
a surrogate for human skin, including from other animals and engineered skin.9,10,11Based on 
morphological and functional data, domestic pig skin seems to be the closest to human 
skin,12,13,14 and is often used as a substitute in various human skin studies.10,15 Processes like 
transdermal drug diffusion are mechanistically related to the chemical structure and composition 
of skin.16,17,18,19 Hence, the similarity of porcine skin in mimicking human skin largely depends 
on the structural and chemical similarity to some extent. Both these properties of skin and their 
evolution over the time should also be examined as accurate histologic reproduction and minimal 
chemical degradation are critical aspects of any skin model. Finally, skin is structurally 
hetergeneous.1 Hence, variations among different samples and of the same histological entities 
within a sample must be accounted to either understand or address reproducibility issues in using 
model systems.  
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While histologic characterization of tissue is routinely accomplished by structural 
imaging, a biochemical characterization typically requires destruction of the structure. 
Destructive methods result in a loss of spatially specific information, which is vital to many skin 
studies, including the diffusion of molecules in skin. Yet, there are few techniques available that 
can simultaneously examine chemistry and structure in a dynamic and facile manner. Emerging 
chemical imaging techniques can potentially aid in this task. For example, Fourier transform 
infrared (FT-IR) spectroscopic imaging holistically measures chemical species in the sample and 
its use has been reported in various biomedical applications.20,21,22Several reports specifically 
describe IR spectroscopic studies on skin,11, 23,24,25,26,27 some of which use porcine skin as the 
model.28,29, 30,31 Most of these studies use the stratum corneum layer of the skin, and some look 
deeper into viable part of epidermis and dermis. While morphological and functional similarities 
between porcine and human skin have been reported, 10, 15 there are no prior reports of complete 
chemical property and stability analysis of porcine skin as a model system itself, and particularly 
its suitability in human transdermal drug delivery studies. The characterization of porcine skin 
using FT-IR imaging will also allow for a direct comparison with prior reports on human and 
engineered skin.11 Hence, we report here a spectroscopic analysis of porcine skin and on its 
suitability as a model system using FT-IR spectroscopic imaging. The characterization is 
morphologic, of histologic analysis and chemical analysis by FT-IR imaging and application of 
statistical analysis. We further examined the suitability of this model for transdermal molecular 
diffusion studies. These results will provide more knowledge and confidence for those who use 
porcine skin as the model system for their studies. 
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5.2 Materials and Methods 
5.2.1 Porcine Skin Sample Preparation 
Fresh porcine skin was obtained from a local slaughter house. There was no attempt to 
control conditions under which the animals are maintained as we desired to capture the natural 
variation in the sample population to be analogous to natural human variation. Each sample was 
cut into 10 mm × 10 mm pieces and was subsequently frozen in liquid nitrogen without the use 
of fixative or embedding medium. Frozen samples were sectioned to 10 µm slices in a cryostat 
(Leica CM-3050-S) and placed on appropriate BaF2, low-e, or glass slides. DMSO-d6 (Sigma-
Aldrich) solution was applied topically to fresh porcine skin for a specified time interval, and 
then wiped off before the skin was frozen and processed following the sample preparation 
procedure. 
5.2.2 Human Skin 
Human skin samples were obtained from Carle Foundation Hospital after institutional 
board review and appropriate anonymization of sources. Tissues were formalin-fixed and 
paraffin-embedded before being sectioned in a SHUR/Sharp™ 4060E Electronic Rotary 
Microtome (Triangle Biomedical Sciences). These sections were placed on low-e glass slides. 
5.2.3 Tissue Staining 
Haematoxylin and eosin staining of paraffin embedded samples has been described in 
Chapter 2. To stain fresh frozen tissue sections, they were fixed in formalin solution for 5 
minutes, followed by three 5-minutes washes in PBS. They were then proceeded directly to the 
eosin staining step and the rest of the procedure was the same as described earlier. 
88 
 
5.2.4 FT-IR Imaging and Data Analysis 
FT-IR imaging procedure has been described in Chapter 3. Here we only describe the 
data analysis steps. Comprehensive data maps (CDM) provides a convenient method of 
graphically displaying data so as to convey the view of signal and variance and identify patterns 
and trends in complex datasets. The data were mean centered using an average for the entire data 
set and the average spectrum is shown above the data. The central data block consists of rows of 
spectra, with each row having a particular set of data associated with it. The display is the 
difference from the average. Supervised pattern recognition approach used here was described 
elsewhere.32,33 FT-IR spectra were analyzed for different types of histological structure to select 
important features for tissue discrimination, which is termed metrics. Next, tissue IR images 
were compared with H&E stained images to manually select tissue classes on the IR images. The 
distribution for each spectral metric for each tissue was evaluated, and these distributions were 
applied to classify IR images. Classified images were qualitatively compared to H&E images as 
the gold standard. Quantitative ROC analysis was then performed based on comparison of 
classified images and manually selected IR tissue regions to evaluate the sensitivity and 
specificity of the classifier. The area under the ROC curve (AUC) was used to predict 
classification confidence. The spectral metrics were then sorted by how they alter the AUC value 
in an iterative process to select a small number of metrics that permit rapid and accurate image 
classification. 
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5.3 Results 
5.3.1 Characterization of Porcine Skin 
The optical microscopic and IR total absorbance images as well as spectra from two 
neighboring sections are shown in Figure 5.1. As apparent in the H&E stained image, the porcine 
skin contains an epidermis layer (comprised of viable epidermis and a stratum corneum layer) 
and a dermis layer (Figure 5.1A).  Some histological appendage structures, including hair and 
hair follicles, blood vessels, Sebaceous glands and immune cells are also evident in the image. 
Various other structures, like sweat glands and nerves are not identified but might also appear. 
The relatively large histological structures are also identifiable in the total absorbance images 
from FT-IR spectroscopic imaging. These images have relatively lower spatial resolution (6.25 
µm resolution here) compared with optical microscopic images, but provide valuable chemical 
information of the sample. The spectra from each structure are plotted and compared, and there 
are some spectral features that are characteristic of each layer, reflecting their different chemical 
compositions and functions (Figure 5.1B). For example, one of the main components of dermis 
is collagen. Hence, the spectrum of dermis shows a characteristic tri-peak around 1200-1300 cm-
1
. The infrared image corresponds to the histologic segmentations commonly observed in optical 
microscopy images after H&E staining, thereby providing both coarse-level structural 
information of the tissue as well as detailed chemical information in the spectrum. The 
appendage skin structures are functionally important and often have significant impact during 
processes like drug diffusion. For example, drug diffusion through hair follicles 34 , 35  is 
significantly different from transdermal diffusion through stratum corneum, and might add 
additional complexity to the study of transdermal diffusion studies. Hence, we focus in this 
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manuscript only on the three major layers, dermis, viable epidermis (hereafter referred to as 
simply ‘epidermis’) and the stratum corneum structure. 
5.3.2 Comparison of Human and Porcine Skin 
Characteristic IR absorption peaks in human skin have been reported in various 
studies.36,37,38 Since the chemical composition of skin is likely to affect the outcome of model 
studies, a comparison of the chemistry of porcine and human is beneficial. More specifically, 
each of the different histologic structures in the skin will have different distributions of various 
chemical constituents, namely the abundance and types of lipids, proteins, carbohydrates and 
nucleic acids. These differences will correspond to differences in specific spectral features. 
Hence, spectral comparisons between human and porcine skins (Figure 5.2) are warranted. A 
human skin section from formalin-fixed and paraffin-embedded sample is plated on a low-e slide 
and scanned in reflectance mode of FT-IR imaging. Notably, the lipid peak of 1740 cm-1 is 
missing in the spectra from human skin. It has been reported that this peak varies significantly in 
samples from different body sites, reflecting the difference in the composition of different types 
of lipids in the stratum corneum.39 This might lead to our observation of missing peak in this 
human skin sample. However, since the porcine and human samples compared here are 
processed differently, there might also be a possibility that the spectral differences we see are 
due to the processing differences. To address this question, a direct comparison of the same 
samples treated differently is desirable (Figure 5.3). One piece of porcine skin is cut into two 
halves with one half for flash freezing and cryosectioning, and the other for formalin fixation, 
paraffin embedding, microtoming and deparaffinization. What should also be noted is that the 
optimal cutting temperature (OCT) compound has been known to interfere with tissue spectra in 
infrared measurements, 40 therefore, instead of embedding the sample into OCT, the sample is 
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frozen in liquid nitrogen without OCT support and OCT is only used to attach the sample to 
sample plate in cryostat and not present in the tissue sections.  The results indicate that the peak 
of 1740 cm-1 is retained in the fresh porcine sample, but missing from the fixed porcine sample, 
indicating that the differences in sample processing procedures are very likely to be the reason 
for the missing peak. The peak of 1740 cm-1 is likely from exogenous lipid secreted by glands 
like sebaceous gland and remains in fresh samples.  But in fixed samples it either undergoes 
some chemical bonding changes during fixing, or more likely is washed away by various 
solutions during sample processing. This exogenous lipid interpretation is also consistent with 
our observation that the highest intensity of this peak in fresh is in stratum corneum. Also to be 
noted here, paraffin is not completely removed in the fixed sample, as indicated by the increased 
intensity of peaks around 2800-3000 cm-1. At the same time no OCT is detected in the fresh 
sample, showing the simplicity of this method without the need to remove the additional matrix 
in samples.  
Overall, although there are some slight differences such as peak position shift and 
different center of gravity in some locations, there is significant overlap in spectral features of 
human and porcine skin (Figure 5.2). The spectral features of human and porcine skins in 
epidermis and dermis have been also summarized in Table 5.1. Porcine samples differ in both 
intensity and position of some spectral features, indicating the abundance and environment of 
some biomolecules are likely different. There might be other sources for the observed differences, 
most notably the different sample preparations as we discussed earlier. The variations might also 
arise from the larger scattering related spectral distortions.41,42 In summary, spectroscopically, 
porcine skin is very close from tissue derived from humans and is reasonably a substitute of the 
spectral properties of human skin. 
92 
 
5.3.3 Spectral Stability and Reproducibility of Porcine Skin 
As previously discussed, stability is an important issue regarding the applicability of 
porcine skin as a model for various studies. The optical structure of the skin is very stable over 
the period of 24 hours (data not shown), but chemical degradation of porcine skin cannot 
obviously be judged by its appearance alone. We examined this aspect of the skin model using 
FT-IR imaging, because subtle chemical changes associated with tissue degradation are likely to 
have an effect on its permeation properties. To estimate the degradation, a freshly-sectioned 
sample is imaged at the same area every 4 hours until 24 hours in room temperature. ROIs from 
epidermis and dermis are selected under the guidance of corresponding histological structure 
information obtained from H&E staining and the special spectral features of different skin layers 
showed above. Spectra of the ROIs at each time point are averaged and the average spectra from 
epidermis and dermis are subsequently compared (Figure 5.4A,B). The spectra match with each 
other very well both in epidermis and dermis, indicating high consistency of the tissue chemistry 
over the period of experiment. A small peak of 1740 cm-1 shows up in epidermis, but is almost 
unnoticeable in dermis, similar to our previous observation in the variability of this peak. To 
visualize and quantify the variances among the samples, Comprehensive Data Map (CDM), a 
recently developed tool,11 is used here (Figure 5.4C,D). The color display represents the 
variation of each spectrum from the mean spectrum, which is normalized in each case using the 
peak absorbance for the Amide I mode. Thus, the magnitude of differences can be considered to 
be the fractional variation from the mean absorbance. The CDM shows that the chemical 
variance is smaller than 5% in epidermis within 24 hours, and it is even smaller in dermis. This 
observation is somewhat unexpected as the dermis is morphologically more heterogeneous. At 
the same time, the epidermis is likely more affected by the environment and may be expected to 
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be chemically more diverse. Spectra collected after 3 days are also analyzed and the variation is 
still below 5% (data not shown). These results suggest the porcine skin tissue samples are quite 
stable within the time frame of most common experiments, and therefore might be considered as 
a model system for these experiments.  
Another concern about the porcine skin model is the reproducibility of samples collected 
at different times or from different animals. Hence, we repeated the stability experiments for 
samples from four different pigs for 24 hours and repeated the analysis above - the ROIs are 
averaged and plotted(Figure 5.5A,B) while CDMs are used to visualize the variation. The results 
indicate that highest variation among the samples over 24 hours we analyze is within 10%, and 
comes from the largest Amide-related peaks, which originate from proteins. The fingerprint 
region, which includes most of spectral features, has a variation of about 5%. These results 
indicate that the porcine skin is relatively chemically consistent, and might be suitable to be used 
as a stable model system for many applications. We believe that the higher variation in the 
stretching region of the spectrum likely arises from the larger scattering related spectral 
distortions, which are not readily apparent in baseline-corrected, normalized spectra. These 
distortions likely decay towards the fingerprint region,43,44,45 making it more stable for analysis. 
The averaging of spectra also likely provides a more consistent result between samples and 
regions, thus helping to alleviate some of the variance.  
5.3.4 Automated Histopathology of Porcine Skin 
Since the variation across animals and over time was small, we attempted to classify 
tissue using previously developed methods to relate spectral features to skin layers. A 3-class 
model of epidermis, dermis and hair is created. The hair is abundant in the porcine skin and 
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relatively large compared to other skin appendage structures. However, the hair follicle is 
comprised of epithelial cells, including various sheath layers and in fact can be considered an 
extension of the epidermis. The commonly referred hair is only the hair shaft, which is 
surrounded by hair sheaths inside the skin. Hair shaft is highly keratinized and distinct from the 
hair sheaths, and therefore classified as “hair” here. A modified Bayesian classifier is tested 
using 76 spectral features consisting of normalized peak absorbance, peak positions and center of 
gravity of features that are termed metrics. The classifier is trained using 5460, 5490 and 1039 
pixels of epidermis, dermis and hair respectively from 4 samples. The classifier is then applied to 
a new sample for validation. We did not extensively validate the classifier as the variation in 
spectra between samples and within samples is much smaller than the spectral differences 
between the classes. The final classification corresponds well to the histological structure from 
H&E staining (Figure 5.6A,B), with clear distinction of three classes, epidermis, dermis and hair. 
It is worth noting that some accessory structure, likely glands, are accurately picked up by the 
classifier and classified as epidermis (epithelia), since they are epithelial cells by nature. 
Quantitative evaluation is performed by applying the classifier and observing the ROC curve. 
The area under curve (AUC) shows a high AUC value of >0.97, indicating very accurate 
classification using ~20 metrics. We believe that the 20 metrics likely are needed to account for 
the heterogeneity of classes in this three-layer model. 
5.3.5 Preliminary Studies of Transdermal Diffusion in Porcine Skin 
As we have seen, the porcine skin is remarkably stable and consistent structurally and 
spectrally. We emphasize that these results of consistent structure and chemistry need to be 
validated in the context of use of the model. For example, the small differences may exert a 
disproportionate effect and may be significant for a particular application. One common 
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application of skin model is to study transdermal drug diffusion. With the availability of FTIR 
imaging, it becomes easier to track molecule distribution within the skin in a quantitative manner. 
IR imaging has been reported to monitor the spatial distribution of exogenous materials in skin, 
such as drug delivery agents and permeation enhancers in skin.46,47,48 
Here, we tested the stability of this model to study transdermal drug diffusion using FTIR 
imaging. Dimenthylsulphoxide (DMSO) is one of the earliest and most widely studied 
penetration-enhancing materials. It is often used in many areas of pharmaceutical sciences as a 
universal solvent. We will use DMSO diffusion for the proof-of-concept experiments. 
Deuterated-DMSO (DMSO-d6) is selected as the test molecule, because the deuterium derivative 
produces distinct peaks in normally unoccupied part of the IR spectrum, including two peaks at 
2126 cm-1 and 2254 cm-1, which do not overlap with any spectra features of skin tissue itself 
(Figure 5.7A). DMSO-d6 is applied topically to the surface of the skin, which is later flash 
frozen and cryo-sectioned vertical to the stratum corneum surface. Slices of samples are 
examined using FT-IR imaging. The signal of DMSO-d6 within our skin sample is very weak 
and masked by the high spectral noise that results from a short acquisition time, making the 
molecular signature difficult to track. Therefore, we employed a recently developed technique to 
reduce the noise levels49. Briefly, the approach consists of using the minimum noise fraction 
(MNF) transform to provide factorized orthogonal spectral data. Relatively signal-rich parts of 
the feature space are then employed for an inverse transform to efficiently reject noise such that 
the two peaks of 2126 cm-1 and 2254 cm-1 are readily apparent (Figure 5.7B). The absorbance 
images at these two positions represent the concentration of DMSO-d6 and demonstrate a 
gradient as well as a distribution within the skin (Figure 5.7C). There was generally a higher 
level of DMSO-d6 in epidermis, in particular stratum corneum region and a decreasing presence 
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in the dermis. It must be noted that the absorbance values per pixel of the molecules are rather 
small indicating that even parts per thousand molecule concentration can be readily measured 
using FT-IR imaging. To test the stability of this model, the same area is imaged every 4 hours 
for 24 hours. The spectra from each time point are processed and compared using CDM tool 
(Figure 5.7D). It appears that the variation of spectra at the two peak regions is within 10% over 
the period of 24 hours. This demonstrates that the porcine skin model is stable and in 
combination with FTIR imaging is likely to be very helpful for the studies of trans-dermal drug 
diffusion. 
 
5.4 Conclusions 
Here, we have characterized structural and chemical properties of porcine skin using FT-
IR imaging. Our results indicate porcine skin is very close to human counterpart both structurally 
and chemically. The chemical properties of porcine skin are very stable over the time in room 
temperature, and are relatively consistent among different samples. A preliminary transdermal 
diffusion study is also conducted on porcine skin. The marker molecules can be traced across the 
skin depth using FT-IR imaging, and a concentration profile can be quantitative characterized, 
providing a new way of studying transdermal diffusion. Hence, porcine skin is likely to be an 
attractive tool for studying dynamics of materials for human skin using spectroscopy.  
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5.5 Figures 
 
Figure 5.1 Porcine skin structure and characterization. (A) Histology of porcine skin 
can be observed from serial tissue sections in brightfield optical microscopy images 
after H&E staining (left) and in IR absorbance images, respectively. The color bar 
at the right indicates low (black) to high (red) absorbance. Some of the visible skin 
structures are noted in the images, including stratum corneum (SC), epidermis (E), 
dermis (D), hair (H), hair follicle (HF), blood vessel (BV), immune cells (IC) and 
sebaceous gland (SG). The gaps within the dermis are generated by the tearing 
during cryosectioning. (B) IR spectra of single pixels from each of the structure are 
plotted after piecewise baseline subtraction, providing detailed chemical 
information of each skin structure.  
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Figure 5.2 Comparison of IR spectra from human and porcine skin. P, porcine skin; 
H, human skin. Spectra from pixels in stratum corneum (SC), epidermis and dermis 
layers of human and porcine skin are normalized to Amide-I peak and plotted.  The 
peak of 1740 cm-1 (marked with asterisk) is missing in human samples. 
 
Figure 5.3 Comparison of IR spectra from porcine skin samples processed in two 
different ways. The blue spectra are from formalin-fixed and paraffin embedded 
samples, and the red spectra are from fresh samples. Spectra from pixels in stratum 
corneum, epidermis and dermis layers of porcine skin are normalized to Amide-I 
peak and plotted.  The spectra of paraffin and O.C.T., two matrixes used in tissue 
processing, are also shown. 
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Figure 5.4 Chemical analysis of porcine skin sample stability over the time. A fresh 
porcine sample is imaged at the same area every 4 hours until 24 hours in room 
temperature. Spectra of the ROIs from epidermis (A) and dermis (B) at each time 
point are averaged and compared. CDM is used to visualize the differences among 
spectra from different time points at epidermis (C) and dermis (D). Each spectrum is 
represented by a row of color bar designated by the hour of point. 
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Figure 5.5 Chemical analysis of porcine skin sample-sample variations. Four fresh 
porcine samplesare imaged at the same areas every 4 hours until 24 hours in room 
temperature. Average spectra of the ROIs from epidermis (A) and dermis (B)from 
each sample at each time point are compared.  
 
 
Figure 5.6 Histology model and automated classification of porcine skin. (A) Porcine 
skin is stained with H&E. (B) classification of porcine skin using a 3-class classifier. Red: 
epidermis; green: dermis; blue: hair. (C) ROC analysis of the classifier demonstrates that 
all three classes achieve an AUC above 0.97. 
 
101 
 
 
Figure 5.7. Molecular diffusion in porcine skin tracked using FT-IR imaging. (A) IR 
spectra of DMSO, DMSO-d6 and a pixel from epidermis of DMSO-d6 diffused 
porcine skin.  The peaks of 2126 cm-1 and 2254 cm-1 are not observed from the raw 
spectrum of the skin pixel. (B) MNF transform of the skin spectra minimizes noise in 
skin spectra and reveals the peaks of 2126 cm-1 and 2254 cm-1. (C) Infrared 
absorbance images at 2126 and 2254 cm-1 from DMSO-d6 diffused porcine skin show 
a gradient of DMSO-d6 across the skin depth. An absorbance image at 1554 cm-1 
showing protein content is also given to show the histological structure of the skin 
section. (D) The stability of the model in detecting molecule diffusion is examined by 
comparing the spectra from images taken at the same location in a time span of 24 
hours. The CDM tool shows a variation of about 10%. 
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5.6  Tables 
Table 5.1 Assignment of IR spectral features in human and porcine skin. Results are 
reported from compilations in the literature [ref.11,36,37,45] and from analysis of this 
study’s skin samples. 
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CHAPTER 6 
QUANTITATIVE CHARACTERIZATION  
OF TRANSDERMAL DIFFUSION 
6.1 Introduction 
Skin is a dynamic and living tissue and its stratum corneum (SC) structure is the main 
barrier to permeation.  Drug permeation across the SC and other skin layers is a complex process 
and the exact mechanisms of penetration are often unclear.1 For transdermal drug delivery, it is 
important to visualize the time course and local distribution of a drug topically applied to skin 
surface, as information relating to permeability can be deduced from the spatiotemporal profiles 
of the drug concentration.2,3 Hence, there is a need to develop methods that can characterize 
diffusing drugs as well as skin structure. 
Franz diffusion cell has long been used to study drug diffusion,4,5 in which the amount of 
drug permeated through a membrane is recorded. It is especially useful in monitoring the 
accumulative drug penetration over the time, which can provide valuable information related to 
optimal drug delivery. However, these methods provide very little information about the drugs 
within skin. The spatial distribution of drugs within skin is important because it is closely related 
to two basic permeation parameters, the diffusivity of a drug in various layers of skin and the 
partition coefficient of a drug between its vehicle and skin. Partition coefficient is not directly 
available from Franz cell experiments, and the apparent diffusivity can only be obtained when 
the skin is considered to be a single uniform layer. A widely used alternative to determine spatial 
distribution is tape stripping, whereby skin surface is removed layer by layer with adhesive tape. 
This method has been used to study molecular distribution,6,7,8 but it can only give information in 
the direction perpendicular to the surface. The depth of penetration that can be analyzed is also 
limited. Additional work is also required to quantify the amount of SC removed and the 
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permeated molecules. 3-D confocal Raman has been used for diffusion studies.9,10,11,12 This 
method has the advantage of providing structural and molecular information across the skin 
depth without any destructive treatment. However, it has limitations similar to those in tape 
stripping, because it is essentially a one-dimensional depth profiling tool due to speed and does 
not provide exceptional penetration. Though non-linear Raman technologies have been recently 
developed, its instrumentation is complex and sensitivity may be limited. A more straightforward 
and quantitative approach will be very helpful in better understanding of transdermal drug 
diffusion. 
FT-IR spectroscopy has been used as a fast alternative to measure skin content or drug 
concentration in tape stripping studies.13,14,15,16 Most notably, attenuated total reflectance (ATR) 
spectroscopy has been often employed in these studies. FT-IR imaging, which combines the 
spatial specificity of optical microscopy with the molecular selectivity of vibrational 
spectroscopy, presents the advantage of providing spatial and molecular information 
simultaneously from samples. It has previously been used to study drug permeability. A 
combination of micron scale optics and ATR has been used by Kazarian group.17,18,19,20,21 These 
studies have improved our understanding of drug diffusion, since this method can provide 
information from X-Y direction. However, the SC is laid flat on top of the ATR crystal in these 
experiments and it is essentially a modified Franz cell experimental setup, therefore still lacking 
spatial information across the skin depth.  
One way to obtain the molecular distribution inside skin is to cut thin sections in the 
direction perpendicular to the skin surface and expose the skin layers for measurement. This 
approach has been used to observe the depth distribution of several endogenous and exogenous 
molecules.22 , 23  A more quantitative approach will likely be more useful in determining the 
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important transdermal diffusion performance. At the same time, with the availability of higher 
spatial resolution FT-IR imaging tools, sufficient data can now be obtained from stratum coneum, 
which is often only about 10-20 µm thick.  One of these tools is ATR FT-IR imaging with a 
spatial resolution of 1.56 µm. 
In this work we measure diffusion profiles of cyanophenol inside porcine skin using ATR 
FT-IR imaging on tissue sections, and analyze important diffusion parameters quantitatively. The 
effect of permeation enhancers on drug diffusion is also studied.   
 
6.2 Materials and Methods  
6.2.1 Drug Diffusion in Porcine Skin 
Fresh porcine skin was obtained locally and used within 30 minutes. Cyanophenol 
(Sigma-Aldrich) was dissolved in water or dimethyl sulfoxide (DMSO) (Sigma-Aldrich) at 
desired concentrations. Each drug solution was contained in a homemade deep well and applied 
topically to fresh porcine skin for a specified time interval and then removed and wiped off 
before the skin was frozen in liquid nitrogen vapor and sectioned into 10 µm slices in a cryostat 
(Leica CM-3050-S). A constant drug concentration in the solution was ensured by a large 
volume of the solution in the reservoir. 
6.2.2 FT-IR Imaging 
IR spectroscopic images of tissue sections were collected using the Perkin-Elmer 
Spotlight 400 imaging spectrometer in ATR mode. A spatial pixel size of 1.56 µm and a spectral 
resolution of 4 cm-1 were employed, with 2 scans averaged for each pixel over the entire mid-
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infrared range. An IR background image was acquired with 120 scans co-added at a location on 
the substrate where no tissue is present. A ratio of the background to tissue spectra was then 
computed pixel-by-pixel to remove substrate and air contributions to the spectral data. All 
spectra were piecewise baselined. A Minimum Noise Fraction (MNF) transform was used to 
reduce spectral noise.24 All further computation was performed using programs written in-house 
in ENVI/IDL.  
 
6.2.3 Quantitative Analysis  
Drug diffusion through skin SC is generally considered to follow Fickian diffusion 
through a simple and homogeneous membrane. The concentration profile of the drug, or Cx as a 
function of position x and time t, is given by the solution to Fick’s Second Law: 25,26 
C = KC 1 − xL − 2πsinnπx/Ln e/

 !
" 
where L is the diffusion pathlength of the chemical, or in this case the thickness of SC. Cveh is the 
concentration of chemical in its vehicle, in this case its concentration in the applied solution. D is 
its diffusivity and K is the SC/vehicle partition coefficient. The boundary conditions are: 
(i) at x = 0, C = Cx=0 = K*Cveh, t ≥ 0, 
(ii) at x = L, C = 0, t ≥ 0, and 
(iii) at 0 < x < L, C = 0, t = 0. 
After obtaining the Cx from concentration profiles of drug across the SC, nonlinear 
regression was used to obtain the best fit and then deduce the important parameters of 
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permeation, the partition coefficient K and the diffusion coefficient D. Lag time tlag was 
calculated as 6D/L2 and permeability P is K*D/L. 
 
6.3 Results 
We have previously reported that FT-IR imaging is capable of detecting deuterated 
DMSO in the context of porcine tissue and providing its concentration gradient across skin. 27 
Cyanophenol is a model compound that has a distinct C≡N stretching mode centered around 
2224 cm-1, a spectral region in which there are no other features in human and animal tissue 
samples (Figure 6.1A, B). Therefore, the spectrally distinct nature of the two compounds can be 
used as a model system in studying multicomponent diffusion. The spectra of cyanophenol in the 
DMSO and porcine skin are shown (Figure 6.1B). When the concentration of cyanophenol is 
very low, its spectra might be masked by the spectral noise, making the molecular signature at 
2224 cm-1 difficult to track. In such cases, minimum noise fraction (MNF) transform was 
employed to reduce the noise levels and reveal the spectral peaks (Figure 6.1C). The details of 
this method have been described in our previous studies. 24 
In order to measure the concentration of cyanophenol using its infrared absorbance at 
2224 cm-1, a calibration curve was built (Figure 6.2). Cyanophenol in different concentrations 
were measured using FT-IR spectroscopy. The results were plotted and the linear relationship 
was confirmed between cyanophenol concentration and its infrared absorbance at 2224 cm-1. 
Therefore, the concentrations of cyanophenol compound can now be calculated from its infrared 
absorbance based on this linear calibration curve.  
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The diffusion of cyanophenol inside the skin was imaged using ATR FT-IR imaging. 
Oversaturated cyanophenol solution was applied topically to the porcine skin surface, so that the 
amount of cyanophenol can be considered infinite and the concentration of applied solution was 
assumed to be constant during the experiment. Porcine skin sample was frozen instantaneously in 
liquid nitrogen vapor at different time points and sectioned immediately using a cryostat. The 
full thickness of skin was retained in the section, therefore providing concentration profiles 
across the skin depth. Most importantly, this method measures the tissue samples both 
chemically and histologically, and provides chemical concentration profiles in the context of skin 
substructure, which is unlikely in tape stripping or other similar methods. 
Our FT-IR imaging instrument provides two ways to differentiate skin structure in IR 
images. First, the accompanied optical image of the sample can be used to identify the structure 
of the skin in the IR images, because they are generated from the exact same tissue section. An 
consecutive section stained in H&E is also helpful. The skin layers, including SC, viable 
epidermis and dermis, are clearly distinguishable in the optical image (Figure 6.3A), and can be 
used to match and identify these skin substructures from the corresponding IR image. Second, 
structure differentiation can also be achieved by using the intrinsic chemical information from IR 
images, because each skin structure has its spectral signatures. For instance, the areas highlighted 
in the IR absorbance images of 1744 cm-1 and 1544 cm-1 indicate higher concentration of lipid 
and protein, respectively (Figure 6.3B), providing distinction between SC and viable epidermis. 
More differentiating spectral features are shown in Figure 6.3C, including spectral features in 
regions around 2800-3050 cm-1 and 1200-1300 cm-1. Therefore, skin structure, including the 
exact location of stratum corenum, can be readily deduced from these spectral features.  
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The SC layer is our focus here, because of its prominent barrier function in drug 
penetration. Both methods discussed above were used to determine the location of SC. 
Cyanophenol absorbance profiles across skin were then obtained from the pixels along the 
direction from skin surface towards dermis (Figure 6.3A, B; Figure 6.4B). The absorbance 
profiles of lipid peak at 2854 cm-1 and amide-II peak at 1544 cm-1 were also obtained to show the 
trend of skin chemical composition towards SC (Figure 6.4A). The windows indicate the 
location of SC deduced from the optical image, as well as the spectral feature analysis described 
above. It is clear that cyanophenol had a higher concentration in SC and it had not reached the 
viable epidermis in the sample shown here.  
More diffusion data were collected at different time points (5, 10 and 20 minutes). The 
infrared absorbance images at 2854 cm-1 and 2224 cm-1 were shown (Figure 6.5), representing 
the SC lipid and cyanophenol, respectively. These images indicated that cyanophenol permeated 
deeper over the time and appeared to have reached the viable epidermis after 20 minutes. These 
cyanophenol absorbance images also showed a clear concentration gradient across the skin. 
An example of diffusion data analysis was shown in Figure 6.6. To quantitatively analyze 
the diffusion, the cyanophenol absorbance profiles at 2224 cm-1 were first converted to 
concentration profiles based on the calibration curve. The location of each pixel in the SC was 
also normalized to the percentage of its distance to the skin surface, so that data from SC samples 
of different thickness were comparable. Nonlinear regression was used to obtain the best fit. Two 
important parameters, the partition coefficient K and diffusivity D, were deduced from the curve 
fitting results. In this example, K was determined to be 2.09, and D was 2.83 × 10-10 cm2 s-1. 
The permeability P=K*D/L can also be calculated. It is noted that the lag time Tlag = 6D/L2 was 
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calculated to be a little over 20 minutes. Therefore, it is reasonable to study samples from less 
than 20 minutes of diffusion under similar conditions.  
Data from 5, 10 and 20 minutes of diffusion are summarized in Table 6.1. These results 
are close to what have been previously reported in the literature.16,28 What should be noticed here 
is that the partition coefficient K was significantly larger at the samples collected at early time 
points. One possible explanation is that a portion of the cyanophenol penetrates into SC and 
remains in some pockets there, which has been reported to occur in some cases.1, 29 This will 
result in a higher partition from the solution to skin, therefore generating a higher apparent 
partition coefficient.  
DMSO is one of the earliest and most widely studied penetration enhancer. The effect of 
DMSO on cyanophenol diffusion was studied here by using it as a solvent for cyanophenol. The 
same diffusion experiments were carried out, and the results are summarized in the Table 6.1. 
Our results indicated that DMSO did not facilitate overall penetration in our experimental time 
frame, but the diffusivity of cyanophenol in SC had a 3-5 fold increase in the presence of DMSO 
in comparison with application of aqueous cyanophenol.  
It has been reported that some transdermal penetration enhancers facilitate drug 
penetration by changing the secondary structure of proteins in SC and disrupting the tight 
organization of lipid/corneocyte structure.30,31,32 One of the possible changes comes from the 
amide-I component. The α-helical conformation generates a band at ~1644 cm-1 whereas the β-
sheet conformation gives rise to bands at ~1628 and ~1670 cm-1. This particular secondary 
structure in amide-I was monitored in our experiments. The results showed that a peak at ~1628 
cm-1 emerged when DMSO was used as the solvent (Figure 6.7A). This new peak diminished 
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over the time after DMSO was removed, indicating a possible decreasing level of β-sheet (Figure 
6.7B). This is consistent with previous reports that DMSO-induced secondary structure changes 
can reverse back to predominantly α-helical conformation.32 This conformational change might 
be a reason for the observed diffusivity enhancement. It appears that this enhancement effect 
increases over the time (Table 6.1). This might be due to the accumulative effect from DMSO 
over the time on the conformational changes.  
 
6.4 Discussion 
The IR imaging method we present here provides a holistic measurement of all the 
chemistry information fast and simultaneously and gives important structure information at the 
same time. The image data contain all the information about the tissue background as well as the 
profiles of compound concentration. This method is an excellent addition to current diffusion 
methods, such as Franz cells and tape stripping. Raman spectroscopy is another useful 
vibrational spectroscopy tool in this field. The main advantage of Raman over IR in diffusion 
studies is its ability of non-invasive measurement of the drug diffusion. In addition to reports 
from confocal Raman spectroscopy studies, SRS Raman has recently been used in studying 
transdermal diffusion.33  However, it takes measurements at discrete wavenumbers, and thus 
losing some of the valuable information that can be conferred from a wide spectral range 
measurement. It also requires relatively long time for measurements at current stage, which 
might need to be improved for time sensitive drug diffusion studies. The penetration depth of 
measurements is often limited as well. 
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In our IR measurement, the sample is instantly frozen and diffusion is stopped or largely 
slowed down during the time of preparations and imaging. It is reported that within a reasonable 
time restrain (0.2 Tlag) the concentrations are not significantly affected by the time lapse during 
tape stripping experiments.34 In our case, samples are strictly kept frozen until they are submitted 
for IR imaging, which takes shorter time than 0.2 Tlag. Therefore, we conclude that by optimizing 
our experimental procedures the effect of time lapse between preparation and measurement can 
be minimized. 
In this study we only considered the SC layer and used a single layer uniform model. In 
the case of a small or highly lipophilic drug, permeation through SC might be very fast and 
compounds can reach viable epidermis during the experiments. Under these circumstances, our 
assumption of a single homogeneous media might not be accurate any more. However, the 
concentration profiles generated by our methods remain valuable, as long as a suitable model can 
be developed or adopted from various existing multiphase diffusion models.  
Finally, the results in this study are from porcine skin samples.  The data we obtained are 
close to the published human data. This indicates that besides histological and chemical 
similarities, porcine skin resembles human skin permeation properties reasonably well.  
In summary, we present here a new way of studying transdermal drug diffusion by 
quantitatively determining the spatiotemporal concentration profiles of chemical compounds 
inside skin using FT-IR imaging. This method provides a promising tool to study drug delivery, 
and can also be applied to many other molecular dynamics studies.   
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6.5 Figures 
 
Figure 6.1 Infrared spectral features of chemical compounds in skin tissue. (A) 
Cyanophenol (cyanophenol), a model compound, and DMSO, a common penetration 
enhancer, were used for drug diffusion tracking. (B) cyanophenol has a distinct C≡N 
stretching peak at 2224 cm-1 located in an unoccupied region of tissue samples. (C) 
Minimum noise fraction (MNF) transform was employed to reduce the noise levels 
and reveal the weak spectral peaks.  
 
Figure 6.2. A calibration curve between drug concentration and infrared absorbance. 
Linear curve fitting was used to obtain the best fit of y = ax+b for the relationship of 
cyanophenol concentration and IR absorption at 2224 cm-1. It can be deduced that a = 
2.5×10-4, b = 1.4×10-4 (R2=0.98).  The lower end of the calibration curve was 
generated from aqueous cyanophenol solutions and higher end from cyanophenol 
dissolved in DMSO. 
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Figure 6.3. Skin structure determination using visible and infrared images. (A) 
Optical image of a sample can be used to deduce skin structures. (B) Infrared 
absorbance images highlighting C=O stretching peak at 1744 cm-1, which indicates 
the endogenous lipid in SC, and the amide-II peak at 1544 cm-1, which indicates 
protein content. (C) Two regions with characteristic spectral features differentiating 
different skin structures.  
 
Figure 6.4 Concentration profiles of cyanophenol compound and skin compositions. 
(A) Absorbance profiles at 2854 and 1544 cm-1 indicating lipid and protein 
abundances across the skin depth. (B) Absorbance profile at 2224 cm-1 indicating 
diffusing cyanophenol compound. Boxed region was determined to be the SC based 
on optical image guidance and spectral feature recognition. 
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Figure 6.5 Visualization and quantitation of transdermal diffusion using FT-IR 
imaging. Porcine skin samples were permeated with cyanophenol aqueous solution 
for 5, 10 and 20 minutes. The infrared absorbance images at 2854 and 2224 cm-1, 
representing lipid (L) and cyanophenol (C), showed drug diffusion across SC. 
 
Figure 6.6 Quantitative determination of trandermal diffusion parameters. 
Transdermal diffusion follows Fick’s second law and the solution was used to fit the 
cyanophenol concentration profiles. Nonlinear regression was used to obtain diffusion 
parameters. The partition coefficient K was deduced to be 2.09, diffusivity D is 
2.83×10-10 cm2 s-1. The sample was permeated with cyanophenol aqueous solution for 
10 minutes. 
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Figure 6.7 Secondary structural change as a result of DMSO penetration enhancer. (A) 
DMSO treated SC showed a partial protein secondary structure change from α-helix 
to β-sheet, as indicated by a new peak around 1628 cm-1. (B) This transformation was 
gradually reversed over time.  
 
6.6 Tables  
Table 6.1. The partition coefficient K, diffusivity D, fitting R2, lag time tlag and 
permeability P were calculated from diffusion data using cyanophenol in aqueous 
solution and DMSO. 
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K 7.29±0.19 2.09±0.07 2.27+0.15 0.71±0.07 0.28±0.03 0.26±0.03
D (10-10 cm2 s-1) 3.10±0.23 2.83±0.25 2.60±0.60 8.15±2.74 11.43±3.11 15.14±6.41
tlag (min) 20.16 22.08 24.04 7.67 5.47 4.13
P (10-3 cm/hr) 5.40 1.42 1.42 1.39 0.77 0.94
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CHAPTER 7 
QUANTITATIVE CHARACTERIZATION OF ARTERY AND 
 ITS APPLICATION IN DIFFUSION STUDIES 
7.1 Introduction 
Artery is largely an avascular tissue, and the wall can be up to 1 mm thick. Therefore, the 
mass transport between blood and artery is essential to maintain its structure and functions. The 
exchanges usually include smaller molecules such as oxygen, ions, glucose, and amino acids, 
and macromolecules such as growth factors and lipoproteins. They are regularly exchanged to 
keep cells healthy inside the artery walls. Disruptions or imbalances in the transport of these 
molecules might lead to various diseases including atherosclerosis, which is due to lipid 
deposition on the inner wall.1 
Mass transport is also the key to the delivery of drugs to the artery in clinical applications. 
For example, the delivery of antiproliferative drugs released by drug-eluting stents is essential in 
maintaining stent functions. Stents clot at a rate of 0.6% each year after implantation for up to 3 
years2 and remain an issue even years after implantation.3,4 It is reported that delayed healing and 
re-endothelialization might promote thrombosis.5 , 6 , 7  Therefore, drug-eluting stents has been 
widely used to inhibit endothelial function to improve the implantation.8,9,10 However, complete 
appreciation of the role and limitations of drug eluting stents might still require understanding 
the processes of local arterial drug delivery, similar to what has been discussed in transdermal 
drug diffusion in the previous chapter. Improvement in control over local drug delivery is likely 
to help minimize variations of drug levels in tissues and help achieve an optimal balance 
between efficacy and toxicity.11,12,13,14,15 
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The exchange of molecules into and within the arterial wall has been intensively studied 
both experimentally and theoretically in the past.16 However, studies of molecular diffusion and 
distribution often involve the use of fluorescent or radioactive labels. Applications have been 
reported in the transport of serum albumin,17,18 low density lipoproteins (LDL),19,20,21,22,23 and 
horseradish peroxidase.24,25 Similar methods have also been reported in the studies of  drug 
transport and distribution in the blood vessels.26,27,28,29,30,31 
FT-IR imaging, which combines the spatial specificity of optical microscopy with the 
molecular selectivity of vibrational spectroscopy, presents the advantage of providing spatial and 
molecular information simultaneously from samples. Using an attenuated total reflection (ATR) 
apparatus, FT-IR imaging has been used in several drug diffusion studies. 32,33,34,35,36 In these 
studies, no dyes or labels are required because the FTIR spectra contain the signatures of 
vibrational modes indicating specific functionalities of a molecule. It has also been reported in 
investigation of arteries and atherosclerotic plaques,37 ,38  including a drug diffusion study in 
rabbit aorta, where molecule diffusion through the aorta wall was visualized and a temporal 
series of concentration profiles were observed.39 However, the tissue sample used in the study 
was pre-treated and might not preserve all the physical and chemical properties of natural tissues. 
In addition, although the diffusion concentration profiles were obtained, it was still largely a 
qualitative analysis without precise quantitation and analyses of diffusion properties.  
We have developed a new approach to use FT-IR imaging to visualize and quantitate 
transdermal drug diffusion, which has been extensively described and discussed in the previous 
chapter. Our group has made some major progresses in FT-IR imaging, most notably the high 
resolution FT-IR imaging, which allows better identification of cells in the tissue. The spatial 
resolution of FT-IR is limited by the diffraction limit of IR based on the Raleigh criterion. 
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Therefore a spatial resolution of half the wavelength can theoretically be achieved. Two 
approaches have been reported. ATR FT-IR imaging uses a crystal with high refractive index, 
typically germanium or diamond, to increase NA thus spatial resolution. Cynchrotron beamline 
has also been used to improve the spatial resolution to 0.54µm, enabling much improved cell 
identification in FT-IR imaging.40 Most recently, a benchtop high resolution FT-IR imaging 
device has been developed in our group.41 This device implements a 74X objective in an Agilent 
600UMA spectrometer and microscope coupled with a 128x128 FPA detector. The new 
instrument has shown to be able to obtain high resolution (1.1 µm) with good signal-noise ratio. 
Here we propose to apply our new diffusion method to study drug penetration in artery 
using newly developed high resolution FT-IR imaging instrument. We aim to obtain important 
diffusion parameters from concentration profiles while keeping the arteries in their natural states 
during our experiments.  
 
7.2 MATERIALS AND METHODS 
7.2.1 Histology analysis of arteries 
Fresh porcine arteries were obtained locally. Human porcine arteries were obtained from 
a collaborator. Each sample was cut into small pieces and subsequently frozen in liquid nitrogen 
without the use of fixative or embedding medium. Frozen samples were sectioned to 5 µm slices 
in a cryostat (Leica CM-3050-S) and placed on appropriate BaF2, low-e, or glass slides. For 
histology characterization, these slices were stained using haemotoxylin and eosin following the 
protocols described in the early chapters. 
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7.2.2 Drug diffusion in porcine arteries 
Cyanophenol (Sigma-Aldrich) was dissolved in water or dimethyl sulfoxide (DMSO) 
(Sigma-Aldrich) at desired concentrations. Arteries were cut open and extended on a flat surface. 
Each drug solution was supplied in a homemade deep well and applied topically to arteries for a 
specified time interval. A constant drug concentration in the solution was ensured by using a 
large volume of the solution in the well. The drug was then removed and wiped off before the 
sample was frozen in liquid nitrogen vapor. Frozen samples were then sectioned into 5µm thick 
slices in a cryostat (Leica CM-3050-S).  
7.2.3 FT-IR imaging 
IR spectroscopic images of tissue sections were collected using the Agilent 600UMA 400 
imaging spectrometer equipped with 74X objective. A spatial pixel size of 1.1 µm and a spectral 
resolution of 8 cm-1 were employed, with 16 scans averaged for each pixel over the entire mid-
infrared range. An IR background image was acquired with 128 scans co-added at a location on 
the substrate where no tissue is present. A ratio of the background to tissue spectra was then 
computed pixel-by-pixel to remove substrate and air contributions to the spectral data. A mosaic 
image of large area was obtained by stitching all the individual IR images using a program 
written in ENVI/IDL. All spectra were piecewise baselined. A Minimum Noise Fraction (MNF) 
transform was used to reduce spectral noise. All further computation was performed using 
programs written in-house in ENVI/IDL.  
Supervised pattern recognition approach used here has been described in the previous 
chapters. Briefly, FT-IR spectra were analyzed for different types of histological structure to 
select important features for tissue discrimination, which is termed metrics. Next, tissue IR 
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images were compared with H&E stained images to manually select tissue classes on the IR 
images. The distribution for each spectral metric for each tissue was evaluated, and these 
distributions were applied to classify IR images. Classified images were qualitatively compared 
to H&E images as the gold standard. Quantitative ROC analysis was then performed based on 
comparison of classified images and manually selected IR tissue regions to evaluate the 
sensitivity and specificity of the classifier. The area under the ROC curve (AUC) was used to 
predict classification confidence. The spectral metrics were then sorted by how they alter the 
AUC value in an iterative process to select a small number of metrics that permit rapid and 
accurate image classification. 
 
7.3 Results 
In the previous chapter we have reported that FT-IR imaging is capable of detecting 
transdermal diffusion of cyanophenol compound in porcine skin. The same method was used 
here to study transmural diffusion of cyanophenol across porcine arteries. We started with FT-IR 
imaging characterization of porcine artery tissues. Fresh porcine artery tissues were sectioned 
and two consecutive tissue slices were used for H&E staining and high resolution FT-IR imaging, 
respectively. The histological features were readily identified from the H&E image, including 
two of the primary substructure of artery walls, tunica media and tunica adventitia (Figure 7.1A). 
Tunica intima, a thin layer of endothelial cells, was partly visible but not clearly differentiated 
from tunica media in H&E images, which has often been attributed to the sample preparations 
and imaging resolution limit. The associated tissue structures next to arteries, such as muscle and 
fat, were also observed. Some nerves were also observed, although we will not analyze it as a 
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separate structure due to its limited areas thus the small data size.  The accompanied infrared 
image showed the same tissue structures although in lower spatial resolution. Infrared spectra 
from main structures were plotted (Figure 7.1B). Because of the difference in tissue chemistry, 
each spectrum showed its characteristic absorbance at different wavenumbers. For examples, 
collagen is the main component in tunica adventitia, therefore, its spectrum showed a 
characteristic collagen tri-peak feature between 1200-1300 cm-1. As we have discussed in the 
previous chapter, these spectral features provide valuable information in determining tissue 
structures in infrared images. For instance, two absorbance images at 1240 and 1554 cm-1, 
representing collagen and amide peaks respectively, clearly showed various artery structures 
(Figure 7.1C, D). 
Characteristic IR absorption peaks in human artery have been reported in various 
studies.37,39,42,43 Since the transmural diffusion process is mechanistically related to chemical 
composition of artery, a chemical comparison between porcine and human arteries is necessary. 
The different distributions of various chemical constituents, such as the abundance and types of 
lipids, proteins, carbohydrates and nucleic acids, will be indicated in the differences of specific 
spectral features. Hence, spectral comparisons between human and porcine arteries were 
compared (Figure 7.2). Both human and porcine artery frozen tissue sections were examined 
using FT-IR imaging. Overall, although there are some slight differences such as peak position 
shift and different center of gravity in some locations, human and porcine arteries are almost 
identical in most of the important spectral features. The sources of the slight differences we 
observed have been discussed in the earlier chapters. 
Since the spectra of our samples were stable and consistent, and the spatial resolution was 
improved to 1.1 µm, we attempted to classify artery tissues using our previously developed 
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methods to relate spectral features to artery structures. A 4-class model of tunica media, tunica 
adventitia, muscle and fat was created. The tunica intima is very thin and commonly gets lost in 
tissue imaging, so it was not chosen as a separate class. A modified Bayesian classifier was 
tested using 55 spectral features consisting of normalized peak absorbance, peak positions, center 
of gravity and area ratios of features that are termed metrics. The classifier was trained using 
506,866, 495,210, 289,392 and 262,443 pixels of media, adventitia, fat and muscle, respectively. 
The classifier was then applied to a new sample for validation. We did not extensively validate 
the classifier as the variation in spectra between samples and within samples is much smaller 
than the spectral differences between the classes. The final classification corresponded well to 
the histological structure from H&E staining (Figure 7.3A,B), with clear distinction of four 
classes of media, adventitia, muscle and fat. The nerve tissues were not classified individually, 
but were picked up as tunica media, which is not surprising due to the fact that nerve is closest to 
media among all structures in artery. The muscle classification was not optimized yet, as a few 
muscle pixels were classified as media. This is mostly due to the fact that both media and muscle 
are comprised of muscle cells, with media being smooth muscle cells and muscle being cardiac 
muscle cells. More training data will certainly help improve the classification of two muscle cell 
types. Quantitative evaluation was performed by applying the classifier and observing the ROC 
curve (Figure 7.3C). The area under curve (AUC) showed a high AUC value of >0.95 in all 
classes except muscle, which had an AUC value of ~0.9, indicating very accurate classification. 
We believe that only 10 metrics likely are needed to account for the heterogeneity of classes in 
this four-class model. 
Overall, the spectrochemical characterization indicated that porcine artery is a reasonable 
tissue model for human diffusion studies. We have used cyanophenol as a model compound to 
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study transdermal diffusion, because cyanophenol has a distinct C≡N stretching mode centered at 
2224 cm-1 that can be easily tracked in the tissue background (Figure 6.1). The same calibration 
curve we have built for transdermal diffusion studies can be used here as well (Figure 6.2), 
because this curve was generated independent of any specific tissue background.  
Aorta tissue was chosen as the tissue model for transmural diffusion here, because it 
shares essentially the same histological structure as smaller arteries, but has much bigger 
diameter, thus providing larger surface area and deeper penetration distance for our experiments. 
Fresh aorta tissue was cut open and laid flat before cyanophenol was applied on the endothelial 
side of the surface. Artery sample was then frozen instantaneously in liquid nitrogen at different 
time points and sectioned immediately using a cryostat. The concentration profiles of permeated 
cyanophenol within the artery were then measured using FT-IR imaging. Because the full 
thickness of artery was retained in the section, the infrared images provided concentration 
profiles across the artery walls with much higher spatial resolution compared to traditional 
measurements such as tape stripping. Most importantly, this method measures the tissue samples 
both chemically and histologically, and provides chemical concentration profiles in the context 
of artery histology, thus facilitating our quantitative analysis of diffusion events. 
We have discussed in earlier chapters of two ways of differentiating tissue structures in 
our method, either using the accompanied visible image as a guidance, or using the spectral 
features to help recognize the specific structures. The same method was used here to analyze the 
obtained concentration profiles (Figure 7.4). For example, absorbance intensity images at 1650 
and 1204 cm-1 showed the differentiation of two major structure, tunica media and tunica 
adventitia. The infrared absorbance image from 2224 cm-1, the cyanophenol absorbance, showed 
a gradient across both tunica media and tunica adventitia after 60 minutes of diffusion. The 
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concentration profile was then calculated from the calibration curve. Here, we consider three 
layers of artery wall, tunica intima, tunica media and tunica adventitia, as a uniform single layer 
for our preliminary analysis. More complicated multilayer model can be developed if these 
layers need to be differentiated in terms of their diffusion properties.  
Diffusion data were then collected at different time points (5, 10, 15, 30, 60 and 120 
minutes) after cyanophenol in DMSO solution was applied to aorta surfaces. The absorbance 
images at 2224 cm-1, representing the cyanophenol concentrations, at different time points have 
been compiled (Figure 7.5). It can be observed that cyanophenol permeated deeper over the time. 
These CP absorbance images showed a clear temporal diffusion progress and spatial 
concentration gradient across the artery wall. A nonlinear regression method was used to obtain 
the best fit of each curve. The details of the diffusion equations and data fitting method have 
been discussed in the earlier chapter and an example has been given in Figure 6.6. Briefly, we 
assume the diffusion follows Fick’s second law and the solution to the equation was obtained 
and used to fit the concentration profiles. Diffusion parameters can be deduced as a result of the 
curve fitting, including the diffusivity D. The values of the diffusivity at different time points 
were close to what has been reported in the literature, where conventional diffusion measurement 
methods were used. 44 
In conclusion, the method we developed to study molecular diffusion in tissue models 
using FT-IR imaging can be applied successfully to transmural diffusion across artery, in 
addition to the previous transdermal diffusion applications. The information of local drug 
distribution will likely help us to improve the efficacy of medical implants including drug eluting 
stents. 
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7.4 Figures 
 
Figure 7.1 Artery tissue structure and characterization. (A) Histology of artery can be 
observed from brightfield optical microscopy images after H&E staining of a tissue 
section. (B) Spectrum of each artery substructure can be obtained from FT-IR 
imaging of the consecutive tissue section, showing its unique spectral features. (C) 
Infrared absorbance images at 1240 cm-1 and 1554 cm-1, showing collagen and amide 
peaks respectively, differentiate the artery structures. TM: tunica media; TA: tunica 
adventitia; M: muscle; F: fat; N: nerve. 
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Figure 7.2 Comparison of IR spectra from human and porcine arteries. Spectra from 
pixels in tunica media, tunica adventitia and muscle of human and porcine artery 
tissues were normalized to Amide-I peak and plotted. Spectra from porcine tissue 
indicated an overall resemblance of those from human arteries. 
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Figure 7.3 Histology model and automated classification of porcine artery. (A) 
Porcine artery is stained with H&E. TM: tunica media; TA: tunica adventitia; M: 
muscle; F: fat; N: nerve. (B) Classification of porcine skin using a 4-class classifier. 
Green: tunica media; blue: tunica adventitia; yellow: muscle; red: fat. (C) ROC 
analysis of the classifier demonstrated that three classes achieved an AUC above 0.95 
with the exception of muscle class with an AUC about 0.9. Only about 10 metrics are 
needed to account for the heterogeneity of classes. 
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Figure 7.4 An example of FT-IR imaging analysis of cyanophenol diffusion in artery 
walls. (A) Infrared absorbance images at two different wavenumbers of 1650 and 
1204 cm-1 showed a clear differentiation of tunica media (TM) from tunica adventitia 
(TA). This information in turn can give a guidance of the location of cyanophenol 
(CP) in the artery wall, which is indicated by the absorbance image at 2224 cm-1. (B) 
A profile of cyanophenol absorbance in artery wall, which can be translated to a 
concentration profile of cyanopheol based on the calibration curve. A 60-minute 
diffusion sample was used here. 
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Figure 7.5 Cyanophenol diffusion over the time. Infrared absorbance images at 2224 
cm-1, representing cyanophenol, at different diffusion times showed a clear drug 
penetration process. The concentration profiles were obtained from these images and 
diffusion parameters were deduced using a curve fitting method on these profiles. 
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SUMMARY 
In this thesis project, we studied molecular dynamic changes in both in vitro and ex vivo 
tissue model systems using FT-IR imaging. In particular, we showed that we were able to detect 
tumor-associated chemical changes in stroma that appears to be structurally normal and we also 
determined the distance of this change can reach. This is very valuable for potential clinical 
applications, such as early tumor diagnosis and prognosis, because we provided a way to monitor 
potential tumor markers before a pathologist can observe any histological evidence of 
malignancy in stroma regions. 
Our drug diffusion studies in ex vivo tissue models are also a significant progress. Unlike 
conventional transdermal studies using Franz cells, we were able to develop a new method using 
our FT-IR imaging technology and determine drug concentration profiles inside the tissue, which 
is an important piece of information regarding the mechanism of drug penetration. We showed 
that we can do that while knowing the context of exact tissue structure, which is difficult to do 
using the conventional tape stripping methods.  Finally, we showed that important permeation 
parameters and conclusions can be obtained by quantitatively analyzing the concentration 
profiles using the method we developed here. This study provides a very important tool to 
pharmaceutical, cosmetic and medical device communities to study the mechanism of drug 
penetration and to obtain the optimal balance between drug toxicity and efficacy. 
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APPENDIX 
MATHEMATICS OF TRANSDERMAL DIFFUSION  
A.1 Background 
Skin is a multi-layer and heterogeneous tissue. It is very complex and varies significantly 
across different species. Even samples from different body sites of the same person or animal can 
vary enormously. Adding the facts that skin is largely a live tissue in many applications, skin is 
often regarded as a difficult system for mathematical modeling. It is even more complicated to 
model the behavior of drug transdermal penetration in skin, because several molecular 
penetration pathways are present in structures.  
However, the problem can often be simplified with reasonable assumptions. Simple 
mathematical modeling, such as Fick’s second law of diffusion, has been applied to fit the 
experimental data and obtain penetration parameters. 1 , 2  Two types of scenarios are most 
commonly considered for transdermal drug penetration: 1. where infinite does of drug is applied; 
2. where a small finite dose is applied. The difference is that drug in the first scenario does not 
deplete and a pseudo-steady-state permeation will eventually be reached, while in the second 
scenario there will be no pseudo-steady-state.3,4,5 Fick’s diffusion laws have been used to study 
both scenarios. 
 Fick’s first law states that the rate of transfer of permeant is proportional to the 
concentration gradient.  
dx
dCDJ −=     (Equation 1) 
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where J is the flux, the amount of permeant passing through a unit area per unit time, D is the 
diffusion coefficient and dC/dx is the concentration gradient. 
 Fick’s second law can be derived from Equation 1. In the case of unidirectional diffusion, 
such as what we are studying in transdermal diffusion, it can be expressed as: 
2
2
t x
CDC
∂
∂
=
∂
∂
  (Equation 2) 
where t is the time. Therefore, the rate of concentration change with time at a point is 
proportional to the rate of change in the concentration gradient at that point. 
 What must be noted is that many assumptions are used here in order to apply Fick’s laws 
in the studies. For examples, the skin, often times stratum corneum, is assumed to be uniform 
and isotropic for the permeants. Permeation through the appendages like hair follicles is assumed 
to be negligible. No interactions between permeants and skin exist and the permeation is solely 
by passive diffusion without any active transport mechanism. And it is assumed that diffusion 
coefficient D is independent of concentration, time or distance. Despite those simplification 
assumptions, numerous studies have indicated that the simple equations fit the experimental data 
very well in many occasions. 
 
A.2 Infinite dosing 
A.2.1. Pseudo-steady-state permeation  
 Mathematical analysis of permeation data usually involves solving Fick’s second law 
using initial conditions and boundary conditions for the experiments. In many diffusion studies, 
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Franz cell experimental design is often used, where a membrane separates two compartments. 
The permeant is added to one compartment, and the other is used for measurement of the 
diffusing substance. After sufficient time, steady-state permeation across the membrane is 
achieved when the concentration gradient stays constant. In this pseudo-state-state condition, 
Equation 2 can be simplified as:  
L
DC
dt
dM 0
=
  (Equation 3) 
where M is the cumulative amount of permeant that diffuses through the skin in time t, C0 is the 
concentration of permeants at the outmost layer of skin, and L is the skin thickness. Because it is 
often difficult to use conventional methods to obtain C0, an additional parameter P, partition 
coefficient between the membrane and vehicle, is used. Because C0=PCv, Equation 3 can be 
transformed to: 
L
DPC
dt
dM v
=
  (Equation 4) 
where Cv is the concentration of permeant in the applied vehicle solution.  
Equation 4 is one of the most widely used equations in skin diffusion data analysis. A 
plot of the cumulative permeation M against time t is typically generated, as shown in Figure A1. 
The lag time can be obtained from the intercept of permeation profile on the time axis. It has 
been shown by Crank that the lag time tlag can be related to the diffusion coefficient by: 
D
L
tlag 6
2
=   (Equation 5) 
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 Therefore, diffusion coefficient D can be easily obtained if the lag time is measured from 
the curve in Figure A1. However, the accurate measurement of skin thickness L is often difficult. 
Because it is a square factor, a small error might introduce significant variation. An alternative is 
to rearrange Equation 4 to: 
vv PC
JLL
PC
dtdMD ==   (Equation 6) 
where dM/dt is defined as the flux (J), the rate of change of cumulative permeant passing 
through the membrane per unit area. The thickness of skin is still needed, but it is no longer a 
square factor as in Equation 5. The partition coefficient P can be measured in separate 
experiments. The flux can also be easily obtained from the curve in Figure A.1.  
Often time a new parameter, termed permeability coefficient Kp, is defined as: 
L
PDK p =   (Equation 7) 
which can then transform Equation 4 to: 
vpCKJdt
dM
==
 (Equation 8) 
 This expression is particularly useful, because now the psudo-steady-state flux J is simply 
the product of the permeability coefficient Kp and concentration in vehicle Cv. Because flux J can 
be easily obtained from the curve in Figure A.1, and Cv is usually know, the permeability 
coefficient Kp can be calculated. Therefore, this parameter of the permeability coefficient Kp is 
more often used than diffusion coefficient D, because of the difficulty of obtaining D. 
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A.2.2. Absorption phase with infinite dosing 
The scenario discussed above requires the establishment of the steady state, which is 
proposed to be at least 2.4 times of the lag time tlag.6 We will also need to consider the finite 
interval of time before the steady-state, which is often termed the absorption phase. Crank has 
analyzed this phase, and concluded that during this time the concentrations changes according to: 
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 (Equation 9) 
where C0 is the concentration at x=0, CL is the concentration at x=L, and initial concentration 
Ct=0 is uniform across the membrane. Apparently when t approaches infinity, the terms involving 
the exponentials vanish, and a simple linear concentration distribution can be obtained. This is 
when the steady-state is established.  
 In our transdermal diffusion experiments, Ct=0 is 0 across the skin membrane, C0=KCv 
according to the definition of partition coefficient K, and CL is assumed to be kept at 0 (“sink” 
condition). Therefore, Equation 9 can be written as: 
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  (Equation 10) 
 This equation is very valuable because instead of relying on temporal profiles of 
cumulative amount of permeant we can now deduce the diffusion coefficient D and partition 
coefficient K based on the spatial concentration profile at any given time point of experimental 
data as shown in an example in Figure A.2. Subsequently, using the derived D and K, we can 
calculate other important parameters such as permeability coefficient Kp and lag time tlag. 
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An important issue here is the choice of diffusion time. Apparently, this period should be 
long enough for a concentration profile to establish. It also has to be short enough that no steady-
state can be reached, because in steady-state, the exponential in Equation 10 vanishes and 
becomes: 
)1(
L
xKCC v −=   (Equation 11) 
where all the information about diffusion coefficient D is lost. It has been suggested that 
therefore the diffusion time should be greater than 0.06 tlag but less than 0.6 tlag.7 
Skin is a multi-layer laminate structure, which consists of stratum corneum, viable 
epidermis and dermis. Majority of drug studies focuses on the stratum corneum layer, because it 
is the main barrier to protect skin again chemical compounds, as well as against water loss, 
microbial pathogens, oxidant stress, and mechanical forces. Therefore, stratum corneum is the 
major rate-limiting structure and the main focus for most of drugs administered for transdermal 
diffusion. In other words, the diffusion in viable skin is so fast compared with stratum conerum 
diffusion that the drug is cleared by cutaneous circulation instantly and the concentration at the 
boundary between stratum corneum and viable skin is always kept at zero. This is also known as 
“sink condition”, and an assumption of single uniform stratum corneum is reasonable.  
While single-layer stratum corneum model is sufficient for most prevalent situations in 
transdermal studies, in certain cases the viable skin becomes the main rate-limiting structure. For 
instance, when a drug is highly lipophilic it might penetrate through stratum corneum very 
quickly but has to be limited in diffusion inside the viable skin. In this case, the same approach 
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can be applied to only consider the viable skin as the diffusion path, while the stratum corneum 
diffusion is negligible.  
 However, when a drug is moderate in both hydrophilicity and lipophilicity, stratrum 
coneum and viable skin can both be limiting factors. Although it is only rarely encountered in 
practical drug applications, it is interesting to take a look. Apparently, a multi-layer diffusion 
model is necessary in this case. Since viable epidermis and dermis has very similar chemical and 
physical properties, it is reasonable to consider them as a single uniform viable skin layer, thus 
simplifying the problem to a two-layer diffusion model as shown in Figure A.3. 
In a two-layer diffusion model, permeation parameters in stratum corneum and viable 
skin are considered to be different, as indicated in Figure A.3. Since our transdermal diffusion 
studies is mostly in the absorption phase with infinite dosing, therefore the diffusion equations 
need to be modified to reflect the nature of the two layer system. The mathematics solution is 
relatively complex to obtain and requires future endeavors.   
 
A.3 Finite dosing 
When a finite dose is given, the steady-state permeation is unlikely to achieve. Instead, 
the cumulative permeation increases to a plateau and stays constant after that as shown in Figure 
A.4. Therefore, the parameters considered are often different from infinite dosing situations. 
Among them, two important parameters are the maximum flux (Jmax) and the time to reach 
maximum flux (Tmax). They have been given as: 
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where δ is the thickness of the finite dose layer.  
Equation 10 can be approximated as 
D
LT
6
2
max =    (Equation 14) 
when a finite does δ is considerably smaller than L. 
Therefore, from the permeation profiles for a finite dose, the apparent diffusion 
coefficient can be obtained using the Equations 12 to 14. We will not go into details here, 
because this is not the scenario for our diffusion studies as we always try to supply infinite 
amount of permeants in our experiments. 
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A.4 Figures 
 
Figure A.1 Permeation profile for an infinite dosing experiment 
 
Figure A.2 A typical concentration profile before steady-state for an infinite dose 
application. Data can be fitted to diffusion equations to deduce penetration 
parameters. 
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Figure A.3 A schematic of two-layer transdermal diffusion model. In this model, we 
need to consider two partition coefficients K1 and K2, two diffusion coefficients D1 
and D2, while the concentration profile in skin will be also divided into two areas of 
C1 in stratum corneum (SC) and C2 in viable skin.  
 
 
Figure A.4 Permeation profile for a finite dosing experiment 
  
Vehicle SC Viable skin
Cveh C1 C2
K1 K2
0 L1+L2
Distance
D1 D2
L1
Fl
u
x
TimeTmax
Jmax
151 
 
A.5 References 
                                                          
1 F. Pirot, Y. N. Kalia, A. L. Stinchcomb, Proc. Natl. Acad. Sci. USA, 1997, 94, 1562-1567. 
2 A. L. Stinchcomb, F. Pirot, G. D. Touraille, Pharm. Res., 1999, 16, 1288-1292. 
3 J. Crank, The mathematics of diffusion, 1975, Clarendon Press, Oxford. 
4 A.C. Williams, Transdermal and Topical Drug Delivery, 2003, Pharmaceutical Press, Lodon, 
UK. 
5 H. A. E. Benson, A. C. Watkinson, Transdermal and Topical Drug Delivery: Principles and 
Practice. 2012, John Wiley & Sons, New Jersey. 
6 A. L. Burge, R. L. Cleek, B. E. Vecchia, Pharm. Res., 1995, 12, 972-982 
7 M. B. Reddy, A. L.  Stinchcomb, R. H. Guy, Pharm. Res., 2002, 19, 292-298 
